<?xml version="1.0"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">24748365</PMID>
      <DateCompleted>
        <Year>2016</Year>
        <Month>03</Month>
        <Day>01</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1573-7365</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>30</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2015</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Metabolic brain disease</Title>
          <ISOAbbreviation>Metab Brain Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Role of social factors on cell death, cerebral plasticity and recovery after stroke.</ArticleTitle>
        <Pagination>
          <StartPage>497</StartPage>
          <EndPage>506</EndPage>
          <MedlinePgn>497-506</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11011-014-9544-1</ELocationID>
        <Abstract>
          <AbstractText>Stroke is a serious global health care problem. It is now is the fourth leading cause of death and the primary cause of adult disability in the United States. Substantial evidence from both experimental and clinical studies has demonstrated that social isolation (SI) can increase stroke incidence and impair recovery. Epidemiological studies demonstrate that an increasing number of patients are living alone, and as the aging population increases, loneliness will only increase in prevalence. SI is increasingly identified as an independent risk factor for all-cause mortality. In contrast, individuals with high levels of social support exhibit more rapid and extensive functional and cognitive recovery after a wide variety of pathological insults, including stroke. Clinical data suggests that SI is an important risk factor for increased mortality and delayed functional recovery following ischemic stroke. Attesting to the importance of mortality and behavioral factors in stroke outcome is that these same effects can be reproduced in animal models of experimental stroke. This has allowed researchers to identify several mechanistic changes that occur with affiliative interactions. These include decreased systemic inflammation, elaboration of growth factors including brain derived neurotropic factor (BDNF), enhanced neurogenesis, and improved neuroimmune responsiveness in group housed animals. These may mediate the beneficial effects of social interaction on improving stroke recovery and reducing neuronal death. In this review we provide an overview of the effects of SI on ischemic injury and recovery and discuss their clinical and therapeutic implications.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Venna</LastName>
            <ForeName>Venugopal Reddy</ForeName>
            <Initials>VR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neuroscience, University of Connecticut Health Center, Farmington, CT, 06030, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McCullough</LastName>
            <ForeName>Louise D</ForeName>
            <Initials>LD</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 NS055215</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 NS077769</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 NSO77769</GrantID>
            <Agency>PHS HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>NS055215</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2014</Year>
          <Month>04</Month>
          <Day>22</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Metab Brain Dis</MedlineTA>
        <NlmUniqueID>8610370</NlmUniqueID>
        <ISSNLinking>0885-7490</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D016923" MajorTopicYN="Y">Cell Death</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009473" MajorTopicYN="Y">Neuronal Plasticity</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020127" MajorTopicYN="Y">Recovery of Function</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012931" MajorTopicYN="Y">Social Environment</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012934" MajorTopicYN="N">Social Isolation</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012959" MajorTopicYN="Y">Socioeconomic Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000071939" MajorTopicYN="N">Stroke Rehabilitation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2014</Year>
          <Month>3</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2014</Year>
          <Month>4</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2014</Year>
          <Month>4</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2014</Year>
          <Month>4</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2016</Year>
          <Month>3</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2016</Year>
          <Month>4</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">24748365</ArticleId>
        <ArticleId IdType="mid">NIHMS588011</ArticleId>
        <ArticleId IdType="pmc">PMC4206683</ArticleId>
        <ArticleId IdType="doi">10.1007/s11011-014-9544-1</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Appelros P, Nydevik I, Viitanen M. Poor outcome after first-ever stroke: predictors for death, dependency, and recurrent stroke within the first year. Stroke; a journal of cerebral circulation. 2003;34:122&#x2013;126.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12511762</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arndt SS, Laarakker MC, van Lith HA, van der Staay FJ, Gieling E, Salomons AR, van't Klooster J, Ohl F. Individual housing of mice--impact on behaviour and stress responses. Physiology &amp; behavior. 2009;97:385&#x2013;393.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19303031</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Avendano M, Kawachi I, Van Lenthe F, Boshuizen HC, Mackenbach JP, Van den Bos GA, Fay ME, Berkman LF. Socioeconomic status and stroke incidence in the US elderly: the role of risk factors in the EPESE study. Stroke; a journal of cerebral circulation. 2006;37:1368&#x2013;1373.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16690902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bartolomucci A, Palanza P, Sacerdote P, Ceresini G, Chirieleison A, Panerai AE, Parmigiani S. Individual housing induces altered immuno-endocrine responses to psychological stress in male mice. Psychoneuroendocrinology. 2003;28:540&#x2013;558.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12689611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, Czajkowski SM, DeBusk R, Hosking J, Jaffe A, Kaufmann PG, Mitchell P, Norman J, Powell LH, Raczynski JM, Schneiderman N, Enhancing Recovery in Coronary Heart Disease Patients, I Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA : the journal of the American Medical Association. 2003;289:3106&#x2013;3116.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12813116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, Graham D, Tsankova NM, Bolanos CA, Rios M, Monteggia LM, Self DW, Nestler EJ. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science. 2006;311:864&#x2013;868.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16469931</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boden-Albala B, Litwak E, Elkind MS, Rundek T, Sacco RL. Social isolation and outcomes post stroke. Neurology. 2005;64:1888&#x2013;1892.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15955939</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bodenant M, Leys D, Debette S, Cordonnier C, Dumont F, Henon H, Girot M, Lucas C, Devos D, Defebvre L, Deplanque D, Leclerc X, Bordet R. Intravenous thrombolysis for acute cerebral ischaemia: comparison of outcomes between patients treated at working versus nonworking hours. Cerebrovascular diseases. 2010;30:148&#x2013;156.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20551630</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bondar NP, Kudriavtseva NN. [Impaired social recognition in male mice with repeated experience of aggression]. Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova. 2005;55:378&#x2013;384.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16033240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burton CR. Living with stroke: a phenomenological study. Journal of advanced nursing. 2000;32:301&#x2013;309.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10964176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bushnell C, McCullough LD, Awad IA, Chireau MV, Fedder WN, Furie KL, Howard VJ, Lichtman JH, Lisabeth LD, Pina IL, Reeves MJ, Rexrode KM, Saposnik G, Singh V, Towfighi A, Vaccarino V, Walters MR, on behalf of the American Heart Association Stroke Council, C.o.C., Stroke Nursing, C.o.C.C.C.o.E., Prevention &amp; Council for High Blood Pressure, R. Guidelines for the Prevention of Stroke in Women: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke; a journal of cerebral circulation. 2014</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC10152977</ArticleId>
            <ArticleId IdType="pubmed">24503673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cacioppo JT, Fowler JH, Christakis NA. Alone in the crowd: the structure and spread of loneliness in a large social network. Journal of personality and social psychology. 2009;97:977&#x2013;991.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2792572</ArticleId>
            <ArticleId IdType="pubmed">19968414</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cacioppo JT, Hawkley LC. Perceived social isolation and cognition. Trends in cognitive sciences. 2009;13:447&#x2013;454.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2752489</ArticleId>
            <ArticleId IdType="pubmed">19726219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cacioppo JT, Hawkley LC, Norman GJ, Berntson GG. Social isolation. Annals of the New York Academy of Sciences. 2011;1231:17&#x2013;22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3166409</ArticleId>
            <ArticleId IdType="pubmed">21651565</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng E, Vickrey B. Is there a relationship between prestroke social isolation and outcomes following stroke? Nature clinical practice. Neurology. 2006;2:16&#x2013;17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16932513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Christakis NA, Fowler JH. The spread of obesity in a large social network over 32 years. The New England journal of medicine. 2007;357:370&#x2013;379.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17652652</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Christakis NA, Fowler JH. Social contagion theory: examining dynamic social networks and human behavior. Statistics in medicine. 2013;32:556&#x2013;577.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3830455</ArticleId>
            <ArticleId IdType="pubmed">22711416</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clark CJ, Guo H, Lunos S, Aggarwal NT, Beck T, Evans DA, Mendes de Leon C, Everson-Rose SA. Neighborhood cohesion is associated with reduced risk of stroke mortality. Stroke; a journal of cerebral circulation. 2011;42:1212&#x2013;1217.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3102433</ArticleId>
            <ArticleId IdType="pubmed">21493914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Craft TK, Glasper ER, McCullough L, Zhang N, Sugo N, Otsuka T, Hurn PD, DeVries AC. Social interaction improves experimental stroke outcome. Stroke; a journal of cerebral circulation. 2005;36:2006&#x2013;2011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16100018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DeVries AC, Craft TK, Glasper ER, Neigh GN, Alexander JK. 2006 Curt P. Richter award winner: Social influences on stress responses and health. Psychoneuroendocrinology. 2007;32:587&#x2013;603.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17590276</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DeVries AC, Joh HD, Bernard O, Hattori K, Hurn PD, Traystman RJ, Alkayed NJ. Social stress exacerbates stroke outcome by suppressing Bcl-2 expression. Proceedings of the National Academy of Sciences of the United States of America. 2001;98:11824&#x2013;11828.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC58815</ArticleId>
            <ArticleId IdType="pubmed">11553785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drage MG, Heinrichs SC. Phenotyping the untouchables: environmental enhancement of behavioral and physiological activation in seizure-prone El mice. Epilepsy &amp; behavior : E&amp;B. 2005;6:35&#x2013;42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15652732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Engesser-Cesar C, Anderson AJ, Basso DM, Edgerton VR, Cotman CW. Voluntary wheel running improves recovery from a moderate spinal cord injury. Journal of neurotrauma. 2005;22:157&#x2013;171.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15665610</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Febinger HY, George A, Priestley J, Toth LA, Opp MR. Effects of housing condition and cage change on characteristics of sleep in mice. Journal of the American Association for Laboratory Animal Science : JAALAS. 2014;53:29&#x2013;37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3894645</ArticleId>
            <ArticleId IdType="pubmed">24411777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fone KC, Porkess MV. Behavioural and neurochemical effects of post-weaning social isolation in rodents-relevance to developmental neuropsychiatric disorders. Neuroscience and biobehavioral reviews. 2008;32:1087&#x2013;1102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18423591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Friedman EH. Neurobiology of depression in stroke patients. Stroke; a journal of cerebral circulation. 1993;24:1762.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8236357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gardner J, Oswald A. How is mortality affected by money, marriage, and stress? Journal of health economics. 2004;23:1181&#x2013;1207.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15556242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gerretsen P, Graff-Guerrero A, Menon M, Pollock BG, Kapur S, Vasdev N, Houle S, Mamo D. Is desire for social relationships mediated by the serotonergic system in the prefrontal cortex? An [(18)F]setoperone PET study. Social neuroscience. 2010;5:375&#x2013;383.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20198536</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Glass TA, Dym B, Greenberg S, Rintell D, Roesch C, Berkman LF. Psychosocial intervention in stroke: Families in Recovery from Stroke Trial (FIRST). The American journal of orthopsychiatry. 2000;70:169&#x2013;181.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10826029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, 3rd, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, American Heart Association Statistics, C. &amp; Stroke Statistics, S. Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014;129:e28&#x2013;e292.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5408159</ArticleId>
            <ArticleId IdType="pubmed">24352519</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, American Heart Association Statistics, C. &amp; Stroke Statistics, S. Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013;127:143&#x2013;152.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23283859</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gordon CJ, Becker P, Ali JS. Behavioral thermoregulatory responses of single and group-housed mice. Physiology &amp; behavior. 1998;65:255&#x2013;262.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9855474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hafner S, Emeny RT, Lacruz ME, Baumert J, Herder C, Koenig W, Thorand B, Ladwig KH, Investigators KS. Association between social isolation and inflammatory markers in depressed and non-depressed individuals: results from the MONICA/KORA study. Brain, behavior, and immunity. 2011;25:1701&#x2013;1707.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21756997</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heffner KL, Waring ME, Roberts MB, Eaton CB, Gramling R. Social isolation, C-reactive protein, and coronary heart disease mortality among community-dwelling adults. Social science &amp; medicine. 2011;72:1482&#x2013;1488.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3090468</ArticleId>
            <ArticleId IdType="pubmed">21492978</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holson RR, Scallet AC, Ali SF, Turner BB. &#x201C;Isolation stress&#x201D; revisited: isolation-rearing effects depend on animal care methods. Physiology &amp; behavior. 1991;49:1107&#x2013;1118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1896492</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holt-Lunstad J, Smith TB, Layton JB. Social relationships and mortality risk: a meta-analytic review. PLoS medicine. 2010;7:e1000316.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2910600</ArticleId>
            <ArticleId IdType="pubmed">20668659</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Horie R, Yamori Y, Nara Y, Sawamura M, Mizushima S. Aggravating effects of isolated caging on the development of hypertension and its complications in stroke-prone spontaneously hypertensive rats (SHRSP) and Wistar-Kyoto rats (WKY). Clinical and experimental hypertension. Part A, Theory and practice. 1991;13:859&#x2013;864.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1773518</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>House JS, Landis KR, Umberson D. Social relationships and health. Science. 1988;241:540&#x2013;545.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3399889</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hsiao YH, Chen PS, Chen SH, Gean PW. The involvement of Cdk5 activator p35 in social isolation-triggered onset of early Alzheimer's disease-related cognitive deficit in the transgenic mice. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2011;36:1848&#x2013;1858.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3154103</ArticleId>
            <ArticleId IdType="pubmed">21544067</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hsiao YH, Kuo JR, Chen SH, Gean PW. Amelioration of social isolation-triggered onset of early Alzheimer's disease-related cognitive deficit by N-acetylcysteine in a transgenic mouse model. Neurobiology of disease. 2012;45:1111&#x2013;1120.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22227002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ikeda A, Iso H, Kawachi I, Yamagishi K, Inoue M, Tsugane S, Group JS. Social support and stroke and coronary heart disease: the JPHC study cohorts II. Stroke; a journal of cerebral circulation. 2008;39:768&#x2013;775.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18239171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang Z, Rompala GR, Zhang S, Cowell RM, Nakazawa K. Social isolation exacerbates schizophrenia-like phenotypes via oxidative stress in cortical interneurons. Biological psychiatry. 2013;73:1024&#x2013;1034.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3638045</ArticleId>
            <ArticleId IdType="pubmed">23348010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Juraska JM, Kopcik JR. Sex and environmental influences on the size and ultrastructure of the rat corpus callosum. Brain research. 1988;450:1&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3401704</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kannangara TS, Lucero MJ, Gil-Mohapel J, Drapala RJ, Simpson JM, Christie BR, van Praag H. Running reduces stress and enhances cell genesis in aged mice. Neurobiology of aging. 2011;32:2279&#x2013;2286.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6016367</ArticleId>
            <ArticleId IdType="pubmed">20106549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karelina K, Norman GJ, Zhang N, DeVries AC. Social contact influences histological and behavioral outcomes following cerebral ischemia. Experimental neurology. 2009a;220:276&#x2013;282.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19733169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karelina K, Norman GJ, Zhang N, Morris JS, Peng H, DeVries AC. Social isolation alters neuroinflammatory response to stroke. Proceedings of the National Academy of Sciences of the United States of America. 2009b;106:5895&#x2013;5900.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2667090</ArticleId>
            <ArticleId IdType="pubmed">19307557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karelina K, Stuller KA, Jarrett B, Zhang N, Wells J, Norman GJ, DeVries AC. Oxytocin mediates social neuroprotection after cerebral ischemia. Stroke; a journal of cerebral circulation. 2011;42:3606&#x2013;3611.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3226880</ArticleId>
            <ArticleId IdType="pubmed">21960564</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaufmann JA, Bickford PC, Taglialatela G. Oxidative-stress-dependent up-regulation of Bcl-2 expression in the central nervous system of aged Fisher-344 rats. Journal of neurochemistry. 2001;76:1099&#x2013;1108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11181830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim ES, Park N, Peterson C. Perceived neighborhood social cohesion and stroke. Social science &amp; medicine. 2013;97:49&#x2013;55.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24161088</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krause N, Shaw B, Liang J. Social relationships in religious institutions and healthy lifestyles. Health education &amp; behavior : the official publication of the Society for Public Health Education. 2011;38:25&#x2013;38.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3043376</ArticleId>
            <ArticleId IdType="pubmed">21169477</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kroenke CH, Kubzansky LD, Schernhammer ES, Holmes MD, Kawachi I. Social networks, social support, and survival after breast cancer diagnosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006;24:1105&#x2013;1111.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16505430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lai MC, Holmes GL, Lee KH, Yang SN, Wang CA, Wu CL, Tiao MM, Hsieh CS, Lee CH, Huang LT. Effect of neonatal isolation on outcome following neonatal seizures in rats--the role of corticosterone. Epilepsy research. 2006;68:123&#x2013;136.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16316743</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lai MC, Lui CC, Yang SN, Wang JY, Huang LT. Epileptogenesis is increased in rats with neonatal isolation and early-life seizure and ameliorated by MK-801: a long-term MRI and histological study. Pediatric research. 2009;66:441&#x2013;447.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19581840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lett HS, Blumenthal JA, Babyak MA, Strauman TJ, Robins C, Sherwood A. Social support and coronary heart disease: epidemiologic evidence and implications for treatment. Psychosomatic medicine. 2005;67:869&#x2013;878.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16314591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leutz W, Nonnenkamp L, Dickinson L, Brody K. Utilization and costs of home-based and community-based care within a social HMO: trends over an 18-year period. International journal of integrated care. 2005;5:e25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1395522</ArticleId>
            <ArticleId IdType="pubmed">16773166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leys D, Deplanque D. Thrombolysis beyond the three-hour time window. Clinical and experimental hypertension. 2006;28:313&#x2013;316.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16833040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lieberwirth C, Liu Y, Jia X, Wang Z. Social isolation impairs adult neurogenesis in the limbic system and alters behaviors in female prairie voles. Hormones and behavior. 2012;62:357&#x2013;366.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3565461</ArticleId>
            <ArticleId IdType="pubmed">22465453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu H, Wang Z. Effects of social isolation stress on immune response and survival time of mouse with liver cancer. World journal of gastroenterology : WJG. 2005;11:5902&#x2013;5904.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4479698</ArticleId>
            <ArticleId IdType="pubmed">16270407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu J, Dietz K, DeLoyht JM, Pedre X, Kelkar D, Kaur J, Vialou V, Lobo MK, Dietz DM, Nestler EJ, Dupree J, Casaccia P. Impaired adult myelination in the prefrontal cortex of socially isolated mice. Nature neuroscience. 2012;15:1621&#x2013;1623.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3729624</ArticleId>
            <ArticleId IdType="pubmed">23143512</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu X, Wu R, Tai F, Ma L, Wei B, Yang X, Zhang X, Jia R. Effects of group housing on stress induced emotional and neuroendocrine alterations. Brain research. 2013;1502:71&#x2013;80.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23380532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Madden KS, Szpunar MJ, Brown EB. Early impact of social isolation and breast tumor progression in mice. Brain, behavior, and immunity. 2013;30(Suppl):S135&#x2013;141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3431437</ArticleId>
            <ArticleId IdType="pubmed">22610067</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marder SR, Roth B, Sullivan PF, Scolnick EM, Nestler EJ, Geyer MA, Welnberger DR, Karayiorgou M, Guidotti A, Gingrich J, Akbarian S, Buchanan RW, Lieberman JA, Conn PJ, Haggarty SJ, Law AJ, Campbell B, Krystal JH, Moghaddam B, Sawa A, Caron MG, George SR, Allen JA, Solis M. Advancing drug discovery for schizophrenia. Annals of the New York Academy of Sciences. 2011;1236:30&#x2013;43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3787879</ArticleId>
            <ArticleId IdType="pubmed">22032400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marsden CA, King MV, Fone KC. Influence of social isolation in the rat on serotonergic function and memory--relevance to models of schizophrenia and the role of 5-HT(6) receptors. Neuropharmacology. 2011;61:400&#x2013;407.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21414329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsumoto K, Nomura H, Murakami Y, Taki K, Takahata H, Watanabe H. Long-term social isolation enhances picrotoxin seizure susceptibility in mice: up-regulatory role of endogenous brain allopregnanolone in GABAergic systems. Pharmacology, biochemistry, and behavior. 2003;75:831&#x2013;835.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12957225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mechakra-Tahiri SD, Zunzunegui MV, Preville M, Dube M. Gender, social relationships and depressive disorders in adults aged 65 and over in Quebec. Chronic diseases in Canada. 2010;30:56&#x2013;65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20302686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moller M, Du Preez JL, Emsley R, Harvey BH. Social isolation rearing in rats alters plasma tryptophan metabolism and is reversed by sub-chronic clozapine treatment. Neuropharmacology. 2012;62:2499&#x2013;2506.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22426240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moller M, Du Preez JL, Viljoen FP, Berk M, Emsley R, Harvey BH. Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine. Brain, behavior, and immunity. 2013;30:156&#x2013;167.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23270677</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morris PL, Robinson RG, Andrzejewski P, Samuels J, Price TR. Association of depression with 10-year poststroke mortality. The American journal of psychiatry. 1993;150:124&#x2013;129.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8417554</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakagawa-Toyama Y, Zhang S, Krieger M. Dietary manipulation and social isolation alter disease progression in a murine model of coronary heart disease. PloS one. 2012;7:e47965.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3480446</ArticleId>
            <ArticleId IdType="pubmed">23112879</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nation DA, Szeto A, Mendez AJ, Brooks LG, Zaias J, Herderick EE, Gonzales J, Noller CM, Schneiderman N, McCabe PM. Oxytocin attenuates atherosclerosis and adipose tissue inflammation in socially isolated ApoE&#x2212;/&#x2212; mice. Psychosomatic medicine. 2010;72:376&#x2013;382.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4784697</ArticleId>
            <ArticleId IdType="pubmed">20368478</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nithianantharajah J, Hannan AJ. Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nature reviews. Neuroscience. 2006;7:697&#x2013;709.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16924259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nithianantharajah J, Hannan AJ. The neurobiology of brain and cognitive reserve: mental and physical activity as modulators of brain disorders. Progress in neurobiology. 2009;89:369&#x2013;382.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19819293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O'Keefe LM, Doran SJ, Mwilambwe-Tshilobo L, Conti LH, Venna VR, McCullough LD. Social isolation after stroke leads to depressive-like behavior and decreased BDNF levels in mice. Behavioural brain research. 2014;260:162&#x2013;170.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4225130</ArticleId>
            <ArticleId IdType="pubmed">24211537</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olson MM, Trevino DB, Islam J, Denner L. The biopsychosocial milieu of type 2 diabetes: an exploratory study of the impact of social relationships on a chronic inflammatory disease. International journal of psychiatry in medicine. 2010;40:289&#x2013;305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21166339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ouimet MA, Primeau F, Cole MG. Psychosocial risk factors in poststroke depression: a systematic review. Canadian journal of psychiatry. Revue canadienne de psychiatrie. 2001;46:819&#x2013;828.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11761633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petrea RE, Beiser AS, Seshadri S, Kelly-Hayes M, Kase CS, Wolf PA. Gender differences in stroke incidence and poststroke disability in the Framingham heart study. Stroke; a journal of cerebral circulation. 2009;40:1032&#x2013;1037.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2676725</ArticleId>
            <ArticleId IdType="pubmed">19211484</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petrea RE, Koyfman F, Pikula A, Romero JR, Viereck J, Babikian VL, Kase CS, Nguyen TN. Acute stroke, catheter related venous thrombosis, and paradoxical cerebral embolism: report of two cases. Journal of neuroimaging : official journal of the American Society of Neuroimaging. 2013;23:111&#x2013;114.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21281383</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Quan MN, Tian YT, Xu KH, Zhang T, Yang Z. Post weaning social isolation influences spatial cognition, prefrontal cortical synaptic plasticity and hippocampal potassium ion channels in Wistar rats. Neuroscience. 2010;169:214&#x2013;222.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20438813</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ros-Simo C, Valverde O. Early-life social experiences in mice affect emotional behaviour and hypothalamic-pituitary-adrenal axis function. Pharmacology, biochemistry, and behavior. 2012;102:434&#x2013;441.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22691868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roy-O'Reilly M, McCullough LD. Sex differences in stroke: The contribution of coagulation. Experimental neurology. 2014</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4127336</ArticleId>
            <ArticleId IdType="pubmed">24560819</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schiavone S, Sorce S, Dubois-Dauphin M, Jaquet V, Colaianna M, Zotti M, Cuomo V, Trabace L, Krause KH. Involvement of NOX2 in the development of behavioral and pathologic alterations in isolated rats. Biological psychiatry. 2009;66:384&#x2013;392.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19559404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schrijver NC, Bahr NI, Weiss IC, Wurbel H. Dissociable effects of isolation rearing and environmental enrichment on exploration, spatial learning and HPA activity in adult rats. Pharmacology, biochemistry, and behavior. 2002;73:209&#x2013;224.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12076740</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shankar A, McMunn A, Banks J, Steptoe A. Loneliness, social isolation, and behavioral and biological health indicators in older adults. Health psychology : official journal of the Division of Health Psychology, American Psychological Association. 2011;30:377&#x2013;385.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21534675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stewart M, Barnfather A, Neufeld A, Warren S, Letourneau N, Liu L. Accessible support for family caregivers of seniors with chronic conditions: from isolation to inclusion. Canadian journal on aging = La revue canadienne du vieillissement. 2006;25:179&#x2013;192.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16821200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stranahan AM, Khalil D, Gould E. Social isolation delays the positive effects of running on adult neurogenesis. Nature neuroscience. 2006;9:526&#x2013;533.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3029943</ArticleId>
            <ArticleId IdType="pubmed">16531997</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stuller KA, Jarrett B, DeVries AC. Stress and social isolation increase vulnerability to stroke. Experimental neurology. 2012;233:33&#x2013;39.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21281636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takatsu-Coleman AL, Patti CL, Zanin KA, Zager A, Carvalho RC, Borcoi AR, Ceccon LM, Berro LF, Tufik S, Andersen ML, Frussa-Filho R. Short-term social isolation induces depressive-like behaviour and reinstates the retrieval of an aversive task: mood-congruent memory in male mice? Journal of psychiatry &amp; neuroscience : JPN. 2013;38:259&#x2013;268.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3692723</ArticleId>
            <ArticleId IdType="pubmed">23182303</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trigg R, Wood VA, Hewer RL. Social reintegration after stroke: the first stages in the development of the Subjective Index of Physical and Social Outcome (SIPSO). Clinical rehabilitation. 1999;13:341&#x2013;353.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10460122</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Umberson D, Montez JK. Social relationships and health: a flashpoint for health policy. Journal of health and social behavior. 2010;51(Suppl):S54&#x2013;66.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3150158</ArticleId>
            <ArticleId IdType="pubmed">20943583</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Venna VR, McCullough LD. &#x201C;Won't you be my neighbor?&#x201D;: deciphering the mechanisms of neuroprotection induced by social interaction. Stroke; a journal of cerebral circulation. 2011;42:3329&#x2013;3330.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3226850</ArticleId>
            <ArticleId IdType="pubmed">21960565</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Venna VR, Weston G, Benashski SE, Tarabishy S, Liu F, Li J, Conti LH, McCullough LD. NF-kappaB contributes to the detrimental effects of social isolation after experimental stroke. Acta neuropathologica. 2012;124:425&#x2013;438.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4065798</ArticleId>
            <ArticleId IdType="pubmed">22562356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Venna VR, Xu Y, Doran SJ, Patrizz A, McCullough LD. Social interaction plays a critical role in neurogenesis and recovery after stroke. Translational psychiatry. 2014;4:e351.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3905235</ArticleId>
            <ArticleId IdType="pubmed">24473442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vogt TM, Mullooly JP, Ernst D, Pope CR, Hollis JF. Social networks as predictors of ischemic heart disease, cancer, stroke and hypertension: incidence, survival and mortality. Journal of clinical epidemiology. 1992;45:659&#x2013;666.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1607905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wallace DL, Han MH, Graham DL, Green TA, Vialou V, Iniguez SD, Cao JL, Kirk A, Chakravarty S, Kumar A, Krishnan V, Neve RL, Cooper DC, Bolanos CA, Barrot M, McClung CA, Nestler EJ. CREB regulation of nucleus accumbens excitability mediates social isolation-induced behavioral deficits. Nature neuroscience. 2009;12:200&#x2013;209.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2721778</ArticleId>
            <ArticleId IdType="pubmed">19151710</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang SH, Zhang ZJ, Guo YJ, Zhou H, Teng GJ, Chen BA. Anhedonia and activity deficits in rats: impact of post-stroke depression. Journal of psychopharmacology. 2009;23:295&#x2013;304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18562439</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Whyte EM, Mulsant BH. Post stroke depression: epidemiology, pathophysiology, and biological treatment. Biological psychiatry. 2002;52:253&#x2013;264.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12182931</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yevchak AM, Loeb SJ, Fick DM. Promoting cognitive health and vitality: a review of clinical implications. Geriatric nursing. 2008;29:302&#x2013;310.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18929179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu SW, Pham TM, Aberg E, Brene S, Winblad B, Mohammed AH, Baumans V. Neurotrophin levels and behaviour in BALB/c mice: impact of intermittent exposure to individual housing and wheel running. Behavioural brain research. 2006;167:1&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16343654</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">24739058</PMID>
      <DateCompleted>
        <Year>2015</Year>
        <Month>09</Month>
        <Day>03</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2024</Year>
        <Month>03</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1465-3419</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>20</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2015</Year>
            </PubDate>
          </JournalIssue>
          <Title>Ethnicity &amp; health</Title>
          <ISOAbbreviation>Ethn Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Ethnic differences in tobacco use during pregnancy: findings from a primary care sample in S&#xE3;o Paulo, Brazil.</ArticleTitle>
        <Pagination>
          <StartPage>209</StartPage>
          <EndPage>217</EndPage>
          <MedlinePgn>209-17</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/13557858.2014.907390</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Tobacco use during pregnancy is a global health concern. To date the majority of research originates in developed countries, thus we have a need to better understand factors related to maternal health in developing countries. We examine the prevalence and correlates of smoking by ethnicity in a sample of pregnant primary care patients in S&#xE3;o Paulo, Brazil.</AbstractText>
          <AbstractText Label="DESIGN" NlmCategory="METHODS">Data were obtained from completed surveys during perinatal care visits in primary care clinics. We examine a sample of 811 pregnant women surveyed during 20-30 weeks of pregnancy. Multiple logistic regression was used to obtain odds ratios (OR) and 95% confidence intervals (95% CI).</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">We found significant ethnic differences in smoking during pregnancy. Compared to White women, Black women were more likely to use tobacco during pregnancy (OR: 1.95; 95% CI: 1.16-3.27). In the fully adjusted model, when accounting for common mental disorders, differences in smoking during pregnancy by ethnicity remained (OR: 1.96; 95% CI: 1.14-3.36).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There are ethnic differences in tobacco use during pregnancy. Clinical implications including universal screening for tobacco use during pregnancy and culturally relevant approaches to smoking cessation are suggested.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tabb</LastName>
            <ForeName>Karen Margaret</ForeName>
            <Initials>KM</Initials>
            <AffiliationInfo>
              <Affiliation>a School of Social Work , University of Illinois , Urbana , IL , USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Hsiang</ForeName>
            <Initials>H</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Menezes</LastName>
            <ForeName>Paulo Rossi</ForeName>
            <Initials>PR</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Azevedo e Silva</LastName>
            <ForeName>Gulnar</ForeName>
            <Initials>G</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chan</LastName>
            <ForeName>Ya-Fen</ForeName>
            <Initials>YF</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Faisal-Cury</LastName>
            <ForeName>Alexandre</ForeName>
            <Initials>A</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R24 HD042828</GrantID>
            <Acronym>HD</Acronym>
            <Agency>NICHD NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R25 TW007490</GrantID>
            <Acronym>TW</Acronym>
            <Agency>FIC NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>T32 HD007543</GrantID>
            <Acronym>HD</Acronym>
            <Agency>NICHD NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>T32 MH020021</GrantID>
            <Acronym>MH</Acronym>
            <Agency>NIMH NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2014</Year>
          <Month>04</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Ethn Health</MedlineTA>
        <NlmUniqueID>9608374</NlmUniqueID>
        <ISSNLinking>1355-7858</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D044383" MajorTopicYN="N">Black People</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011248" MajorTopicYN="N">Pregnancy Complications</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011295" MajorTopicYN="N">Prenatal Care</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011320" MajorTopicYN="Y">Primary Health Care</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017150" MajorTopicYN="N">Public Sector</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012907" MajorTopicYN="N">Smoking</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000208" MajorTopicYN="Y">ethnology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D044465" MajorTopicYN="N">White People</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Brazil</Keyword>
        <Keyword MajorTopicYN="N">common mental disorders</Keyword>
        <Keyword MajorTopicYN="N">disparity</Keyword>
        <Keyword MajorTopicYN="N">pregnancy</Keyword>
        <Keyword MajorTopicYN="N">skin colour</Keyword>
        <Keyword MajorTopicYN="N">smoking</Keyword>
        <Keyword MajorTopicYN="N">tobacco use</Keyword>
      </KeywordList>
      <CoiStatement><b>Conflicts of Interest</b>. The authors have no potential conflicts of interest to disclose.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2014</Year>
          <Month>4</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2014</Year>
          <Month>4</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2015</Year>
          <Month>9</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2016</Year>
          <Month>4</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">24739058</ArticleId>
        <ArticleId IdType="mid">NIHMS583631</ArticleId>
        <ArticleId IdType="pmc">PMC4201645</ArticleId>
        <ArticleId IdType="doi">10.1080/13557858.2014.907390</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>AL-SAHAB B, SAQIB M, HAUSER G, TAMIM H. Prevalence of smoking during pregnancy and associated risk factors among Canadian women: a national survey. BMC Pregnancy Childbirth. 2010;10:24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2885995</ArticleId>
            <ArticleId IdType="pubmed">20497553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>AMASHA H, JARADEH M. Effect of Active and Passive Smoking during Pregnancy on its Outcomes. Health Science Journal. 2012:6.</Citation>
        </Reference>
        <Reference>
          <Citation>AGRAWAL A, SCHERRER JF, GRANT JD, SARTOR CE, PERGADIA ML, DUNCAN AE, MADDEN PAF, RANDOLPH HABER J, JACOB T. The effects of maternal smoking during pregnancy on offspring outcomes. Preventive Medicine. 2010;50:13&#x2013;18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2813884</ArticleId>
            <ArticleId IdType="pubmed">20026103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BARROS FC, VICTORA CG, HORTA BL. Ethnicity and infant health in Southern Brazil. A birth cohort study. International Journal of Epidemiology. 2001;30:1001&#x2013;1008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11689511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>CNATTINGIUS S. The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob Res. 2004;6(Suppl 2):S125&#x2013;40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15203816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DE DA MOTTA GC, ECHER IC, DE LUCENA AF. Factors associated with smoking in pregnancy. Rev Lat Am Enfermagem. 2010;18:809&#x2013;15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20922330</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>EL-KHORAZATY M, JOHNSON A, KIELY M, EL-MOHANDES A, SUBRAMANIAN S, LARYEA H, MURRAY K, THORNBERRY J, JOSEPH J. Recruitment and retention of low-income minority women in a behavioural intervention to reduce smoking, depression, and intimate partner violence during pregnancy. BMC Public Health. 2007;7:233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2020481</ArticleId>
            <ArticleId IdType="pubmed">17822526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>FAISAL-CURY A, MENEZES P, ARAYA R, ZUGAIB M. Common mental disorders during pregnancy: prevalence and associated factors among low-income women in S&#xE3;o Paulo, Brazil. Archives of Womens Mental Health. 2009;12:335&#x2013;343.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19468824</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>GILMAN SE, BRESLAU J, SUBRAMANIAN SV, HITSMAN B, KOENEN KC. Social factors psychopathology, and maternal smoking during pregnancy. American Journal of Public Health. 2008;98:448&#x2013;453.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2253564</ArticleId>
            <ArticleId IdType="pubmed">17600245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>HANNA EZ, FADEN VB, DUFOUR MC. The motivational correlates of drinking smoking, and illicit drug use during pregnancy. Journal of Substance Abuse. 1994;6:155&#x2013;67.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7804015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>HEAMAN MI, CHALMERS K. Prevalence and correlates of smoking during pregnancy: a comparison of aboriginal and non-aboriginal women in manitoba. Birth. 2005;32:299&#x2013;305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16336371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>INO T. Maternal smoking during pregnancy and offspring obesity: Meta-analysis. Pediatrics International. 2010;52:94&#x2013;99.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19400912</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>INO T, SHIBUYA T, SAITO K, OHTANI T. Effects of maternal smoking during pregnancy on body composition in offspring. Pediatrics International. 2011;53:851&#x2013;857.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21496178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>JANE-LLOPIS E, MATYTSINA I. Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs. Drug and Alcohol Review. 2006;25:515&#x2013;536.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17132571</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>JANSEN K, CURRA AR, SOUZA LDDM, PINHEIRO RT, MORAES IGDS, CUNHA MSD, SILVA RAD. Tobacco smoking and depression during pregnancy/Tabagismo e depress&#xE3;o durante a gravidez. Revista de psiquiatria do Rio Grande do Sul. 2010;32:44&#x2013;47.</Citation>
        </Reference>
        <Reference>
          <Citation>KING T, BORRELLI B, BLACK C, PINTO B, MARCUS B. Minority women and tobacco: Implications for smoking cessation interventions. Annals of Behavoiral Medicine. 1997;19:301&#x2013;313.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9603705</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>KROEFF LR, MENGUE SS, SCHMIDT MI, DUNCAN BB, FAVARETTO AL, NUCCI LB. Correlates of smoking in pregnant women in six Brazilian cities. Rev Saude Publica. 2004;38:261&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15122383</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>LASSER KE, BOYD JW, WOOLHANDLER SJ, HIMMELSTEIN DU, MCCORMICK D, BOR DH. Smoking and mental illness: A population-based prevalence study. Journal of General Internal Medicine. 2000;15:79&#x2013;79.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11086367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>LUMLEY J, CHAMBERLAIN C, DOWNSWELL T, OLIVER S, OAKLEY L, WATSON L. Interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews. 2009:3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4090746</ArticleId>
            <ArticleId IdType="pubmed">19588322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>MALTA DC, MOURA EC, SILVA SA, DE OLIVEIRA PPV, SILVA VLDE. Prevalence of smoking among adults residing in the Federal District of Brasilia and in the state capitals of Brazil, 2008. Jornal Brasileiro De Pneumologia. 2010;36:75&#x2013;83.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20209311</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>MARI JD, WILLIAMS P. A Validity Study of a Psychiatric Screening Questionnaire (Srq-20) in Primary Care in the City of S&#xE3;o-Paulo. British Journal of Psychiatry. 1986;148:23&#x2013;26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3955316</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>NILSEN P. Brief alcohol intervention to prevent drinking durign pregnancy: an overview of research findings. Curr Opin Obstet Gynecol. 2009;21:496&#x2013;500.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19797951</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>NGUYEN KH, SUBRAMANIAN SV, SORENSEN G, TSANG K, WRIGHT R. Influence of expereinces of racial discrimination and ethnic identity or prenatal smoking among urban black and Hispanic women. J Epidemiology Community Health. 2012;66:315&#x2013;321.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20974840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>OLDS DL, HENDERSON CR, TATELBAUM R. Prevention of Intellectual Impairment in Children of Women Who Smoke Cigarettes during Pregnancy. Pediatrics. 1994;93:228&#x2013;233.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7510063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>PERREIRA KM, CORTES KE. Race/ethnicity and nativity differences in alcohol and tobacco use during pregnancy. Am J Public Health. 2006;96:1629&#x2013;36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1551957</ArticleId>
            <ArticleId IdType="pubmed">16873756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>PINHEIRO KAT, HORTA BL, PINHEIRO RT, HORTA LL, TERRES NG, DA SILVA RA. Common mental disorders in adolescents: a population based cross-sectional study. Revista Brasileira De Psiquiatria. 2007;29:241&#x2013;245.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17713704</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>PRITCHARD CW. Depression and Smoking in Pregnancy in Scotland. Journal of Epidemiology and Community Health. 1994;48:377&#x2013;382.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1059987</ArticleId>
            <ArticleId IdType="pubmed">7964337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>RIBEIRO VS, FIGUEIREDO FP, SILVA AAM, BATISTA RLF, BARBIERI MA, LAMY F, ALVES MTSSB, SANTOS AM, BETTIOL H. Do socioeconomic factors explain why maternal smoking during pregnancy is more frequent in a more developed city of Brazil? Brazilian Journal of Medical and Biological Research. 2007;40:1203&#x2013;1210.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17713662</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>SILVA LM, SILVA RA, SILVA AAM, BETTIOL H, BARBIERI MA. Racial inequalities and perinatal health in the southeast region of Brazil. Brazilian Journal of Medical and Biological Research. 2007;40:1187&#x2013;1194.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17713668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>SHOFF C, YANG TC. Understanding maternal smoking during pregnancy: Does residential context matter? Social Science &amp; Medicine. 2013;78:50&#x2013;60.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3545052</ArticleId>
            <ArticleId IdType="pubmed">23246395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>VENTURA SJ, HAMILTON BE, MATHEWS TJ, CHANDRA A. Trends and variations in smoking during pregnancy and low birth weight: Evidence from the birth certificate, 1990&#x2013;2000. Pediatrics. 2003;111:1176&#x2013;1180.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12728134</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>WISBORG K, KESMODEL U, HENRIKSEN TB, OLSEN SF, SECHER NJ. Exposure to tobacco smoke in utero and the risk of stillbirth and death in the first year of life. Am J Epidemiol. 2001;154:322&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11495855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>ZHU SH, VALBO A. Depression and smoking during pregnancy. Addictive Behaviors. 2002;27:649&#x2013;658.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12188598</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">24735196</PMID>
      <DateCompleted>
        <Year>2016</Year>
        <Month>02</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2015</Year>
        <Month>01</Month>
        <Day>17</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2042-7174</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>23</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2015</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>The International journal of pharmacy practice</Title>
          <ISOAbbreviation>Int J Pharm Pract</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Ethics in global health outreach: three key considerations for pharmacists.</ArticleTitle>
        <Pagination>
          <StartPage>86</StartPage>
          <EndPage>89</EndPage>
          <MedlinePgn>86-9</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/ijpp.12112</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective of this article is to explore three key ethical tenets that pharmacists should consider prior to participating in global health outreach.</AbstractText>
          <AbstractText Label="KEY FINDINGS" NlmCategory="RESULTS">There are increasing opportunities for pharmacists to be involved in global health outreach; however, little attention has been given to the ethical issues that participation may raise for pharmacists. Pharmacists' widely accepted and basic ethical obligations at home lay the foundation for effective management of these ethical challenges abroad. At home, pharmacists have an ethical obligation to provide the best possible quality of care to the patients for whom they serve. During global health outreach, this involves identifying and mitigating the potential for harm, as well as understanding and respecting cultural differences. Furthermore, pharmacists have an ethical obligation to not only meet individual patient needs, but also community and societal needs, when applicable. In global health outreach, this involves tailoring interventions to the needs of the population served.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Because of their unique skillset, pharmacists have the potential to make significant contributions to global health. Applying ethical principles, such as providing the best possible care, respecting cultural differences and meeting societal needs, provides the foundation for successful global health outreach by pharmacists.</AbstractText>
          <CopyrightInformation>&#xA9; 2014 Royal Pharmaceutical Society.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Romo</LastName>
            <ForeName>Matthew L</ForeName>
            <Initials>ML</Initials>
            <AffiliationInfo>
              <Affiliation>Epidemiology and Biostatistics Program, CUNY School of Public Health, New York, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>DeCamp</LastName>
            <ForeName>Matthew</ForeName>
            <Initials>M</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2014</Year>
          <Month>04</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Int J Pharm Pract</MedlineTA>
        <NlmUniqueID>9204243</NlmUniqueID>
        <ISSNLinking>0961-7671</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D054521" MajorTopicYN="N">Cultural Competency</DescriptorName>
          <QualifierName UI="Q000941" MajorTopicYN="Y">ethics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
          <QualifierName UI="Q000941" MajorTopicYN="Y">ethics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006301" MajorTopicYN="N">Health Services Needs and Demand</DescriptorName>
          <QualifierName UI="Q000941" MajorTopicYN="Y">ethics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010595" MajorTopicYN="N">Pharmacists</DescriptorName>
          <QualifierName UI="Q000941" MajorTopicYN="Y">ethics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011787" MajorTopicYN="N">Quality of Health Care</DescriptorName>
          <QualifierName UI="Q000941" MajorTopicYN="Y">ethics</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">ethics</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">medical outreach</Keyword>
        <Keyword MajorTopicYN="N">medically underserved</Keyword>
        <Keyword MajorTopicYN="N">volunteer</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2013</Year>
          <Month>9</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2014</Year>
          <Month>3</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2014</Year>
          <Month>4</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2014</Year>
          <Month>4</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2016</Year>
          <Month>2</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">24735196</ArticleId>
        <ArticleId IdType="doi">10.1111/ijpp.12112</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">24720388</PMID>
      <DateCompleted>
        <Year>2016</Year>
        <Month>12</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>30</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2168-6602</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>29</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2015</Year>
              <Season>May-Jun</Season>
            </PubDate>
          </JournalIssue>
          <Title>American journal of health promotion : AJHP</Title>
          <ISOAbbreviation>Am J Health Promot</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Do we know how to design effective health coaching interventions: a systematic review of the state of the literature.</ArticleTitle>
        <Pagination>
          <StartPage>e158</StartPage>
          <EndPage>e168</EndPage>
          <MedlinePgn>e158-68</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.4278/ajhp.130510-LIT-238</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To systematically review health coaching interventions regarding effectiveness of health coaching for specific outcomes, optimal intervention approaches, and identification of specific techniques associated with effectiveness.</AbstractText>
          <AbstractText Label="DATA SOURCE" NlmCategory="METHODS">Articles were sourced from CINAHL, Global Health, PsycINFO, Academic Search Complete, Health Source, Psychology and Behavioral Sciences Collection, and Medline.</AbstractText>
          <AbstractText Label="STUDY INCLUSION AND EXCLUSION CRITERIA" NlmCategory="METHODS">Randomized controlled trials were included if the study (1) employed health coaching according to a predefined criterion; (2) clearly reported the use of health coaching; or (3) incorporated the use of coaching.</AbstractText>
          <AbstractText Label="DATA EXTRACTION" NlmCategory="METHODS">Aims, participants, approach, behavior change techniques (BCTs), and findings pertaining to each study were summarized. BCTs were classified according to the CALO-RE taxonomy.</AbstractText>
          <AbstractText Label="DATA SYNTHESIS" NlmCategory="RESULTS">Data were synthesized by cross-tabulation of BCTs with study outcomes.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifteen of 16 eligible studies reported a positive intervention effect in at least one outcome. Nine studies (56%) did not define health coaching; the number of intervention sessions provided ranged from 2 to 48; and in three studies, one or more intervention details were unclear. It was hence difficult to synthesize the studies to adequately address our research questions.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Health coaching is a promising strategy for health improvements; however, future research should ensure clarity in reporting intervention details, clearer definitions of health coaching/theoretical bases, consistency in reporting BCTs, and the inclusion of process variables as outcome measures.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hill</LastName>
            <ForeName>Briony</ForeName>
            <Initials>B</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Richardson</LastName>
            <ForeName>Ben</ForeName>
            <Initials>B</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Skouteris</LastName>
            <ForeName>Helen</ForeName>
            <Initials>H</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
          <PublicationType UI="D000078182">Systematic Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2014</Year>
          <Month>04</Month>
          <Day>10</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Am J Health Promot</MedlineTA>
        <NlmUniqueID>8701680</NlmUniqueID>
        <ISSNLinking>0890-1171</ISSNLinking>
      </MedlineJournalInfo>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001521" MajorTopicYN="N">Behavior Therapy</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015438" MajorTopicYN="Y">Health Behavior</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006293" MajorTopicYN="N">Health Promotion</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000071252" MajorTopicYN="N">Mentoring</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Chronic Disease Prevention</Keyword>
        <Keyword MajorTopicYN="N">Chronic Disease Self-Management</Keyword>
        <Keyword MajorTopicYN="N">Health Behavior Change</Keyword>
        <Keyword MajorTopicYN="N">Health Coaching</Keyword>
        <Keyword MajorTopicYN="N">Health focus: fitness/physical activity, nutrition, stress management, weight control</Keyword>
        <Keyword MajorTopicYN="N">Manuscript format: literature review</Keyword>
        <Keyword MajorTopicYN="N">Setting: health care</Keyword>
        <Keyword MajorTopicYN="N">Strategy: behavior change</Keyword>
        <Keyword MajorTopicYN="N">Target population circumstances: all education/income levels, all geographic locations, all races/ethnicities</Keyword>
        <Keyword MajorTopicYN="N">Target population: youth, adults, seniors</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2014</Year>
          <Month>4</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2014</Year>
          <Month>4</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2016</Year>
          <Month>12</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">24720388</ArticleId>
        <ArticleId IdType="doi">10.4278/ajhp.130510-LIT-238</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">24638966</PMID>
      <DateCompleted>
        <Year>2016</Year>
        <Month>05</Month>
        <Day>05</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-3318</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>24</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2015</Year>
              <Month>Nov</Month>
            </PubDate>
          </JournalIssue>
          <Title>Tobacco control</Title>
          <ISOAbbreviation>Tob Control</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A review of smoking policies in airports around the world.</ArticleTitle>
        <Pagination>
          <StartPage>528</StartPage>
          <EndPage>531</EndPage>
          <MedlinePgn>528-31</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/tobaccocontrol-2013-051364</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To review smoking policies of major international airports, to compare these policies with corresponding incountry tobacco control legislation and to identify areas of improvement for advancing smoke-free policy in airports.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We reviewed smoking policies of 34 major international airports in five world regions, and collected data on current national and subnational legislation on smoke-free indoor places in the corresponding airport locations. We then compared airport smoking policies with local legislation. Additionally, we collected anecdotal information concerning smoking rules and practices in specific airports from an online traveller website.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">We found that 52.9% of the airports reviewed had indoor smoking rooms or smoking areas; smoking policy was unknown or unstated for two airports. 55.9% of the airports were located in countries where national legislation allowed designated smoking rooms and areas, while 35.3% were in smoke-free countries. Subnational legislation restricted smoking in 60% of the airport locations, while 40% were smoke-free. 71.4% of the airport locations had subnational legislation that allowed smoke-free laws to be more stringent than at the national level, but only half of these places had enacted such laws.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Despite the increasing presence of smoke-free places and legal capacity to enact stricter legislation at the local level, airports represent a public and occupational space that is often overlooked in national or subnational smoke-free policies. Secondhand smoke exposure in airports can be reduced among travellers and workers by implementing and enforcing smoke-free policies in airports. Additionally, existing information on smoke-free legislation lacks consistent terminology and definitions, which are needed to inform future tobacco control policy within airports and in the law.</AbstractText>
          <CopyrightInformation>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Stillman</LastName>
            <ForeName>Frances A</ForeName>
            <Initials>FA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Soong</LastName>
            <ForeName>Andrea</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kleb</LastName>
            <ForeName>Cerise</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Grant</LastName>
            <ForeName>Ashley</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Navas-Acien</LastName>
            <ForeName>Ana</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2014</Year>
          <Month>03</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Tob Control</MedlineTA>
        <NlmUniqueID>9209612</NlmUniqueID>
        <ISSNLinking>0964-4563</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014028">Tobacco Smoke Pollution</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D059028" MajorTopicYN="N">Airports</DescriptorName>
          <QualifierName UI="Q000331" MajorTopicYN="Y">legislation &amp; jurisprudence</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003625" MajorTopicYN="N">Data Collection</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011640" MajorTopicYN="N">Public Policy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D061845" MajorTopicYN="Y">Smoke-Free Policy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012907" MajorTopicYN="N">Smoking</DescriptorName>
          <QualifierName UI="Q000331" MajorTopicYN="Y">legislation &amp; jurisprudence</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000074606" MajorTopicYN="N">Smoking Prevention</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014028" MajorTopicYN="N">Tobacco Smoke Pollution</DescriptorName>
          <QualifierName UI="Q000331" MajorTopicYN="N">legislation &amp; jurisprudence</QualifierName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Environment</Keyword>
        <Keyword MajorTopicYN="N">Global health</Keyword>
        <Keyword MajorTopicYN="N">Priority/special populations</Keyword>
        <Keyword MajorTopicYN="N">Public policy</Keyword>
        <Keyword MajorTopicYN="N">Secondhand smoke</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2013</Year>
          <Month>9</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2014</Year>
          <Month>2</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2014</Year>
          <Month>3</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2014</Year>
          <Month>3</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2016</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2015</Year>
          <Month>12</Month>
          <Day>16</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">24638966</ArticleId>
        <ArticleId IdType="pmc">PMC4680153</ArticleId>
        <ArticleId IdType="doi">10.1136/tobaccocontrol-2013-051364</ArticleId>
        <ArticleId IdType="pii">tobaccocontrol-2013-051364</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Levy DT, Ellis JA, May D, et al. Smoking-related deaths averted due to three years of policy progress. Bull World Health Organ 2013;91:509&#x2013;18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3699793</ArticleId>
            <ArticleId IdType="pubmed">23825878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>King B, Tynan M, Promoff G, et al. 
Indoor air quality at nine large-hub airports with and without designated smoking areas&#x2014;United States, October&#x2013;November 2012. MMWR Morb Mortal Wkly Rep
2012;61:948&#x2013;51. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6146a4.htm?s_cid=mm6146a4_e</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23169316</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beatty AL, Haight TJ, Redberg RF. Associations between respiratory illnesses and secondhand smoke exposure in flight attendants: a cross-sectional analysis of the Flight Attendant Medical Research Institute Survey. Environ Health 2011; 10:81.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3190330</ArticleId>
            <ArticleId IdType="pubmed">21943016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>U.S. Department of Health and Human Services. The health consequences of involuntary exposure to tobacco smoke: a report of the surgeon general. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2006.</Citation>
        </Reference>
        <Reference>
          <Citation>Americans for Nonsmokers&#x2019; Rights Foundation [Internet]. Smoking Policies in the 35 Busiest U.S. Airports. [Updated July 2013; cited July 2013]. http://www.no-smoke.org/pdf/smokingpoliciesbusiestairports.pdf</Citation>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention, Morbidity and Mortality Weekly Report. Smoking restrictions in large-hub airports&#x2014;United States, 2002 and 2010. MMWR 2010;59:1484&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21085090</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Airports Council International [Internet]. Passenger Traffic 2011 FINAL. [Updated July 2013; cited August 2013]. http://www.aci.aero/Data-Centre/Annual-Traffic-Data/Passengers/2011-final</Citation>
        </Reference>
        <Reference>
          <Citation>Global Smokefree Partnership [Internet]. Global map of smokefree laws&#x2014;2013. [Updated 2013; cited July 2013]. http://www.globalsmokefreepartnership.org/global-map-of-smokefree-laws-2013/</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization [Internet]. WHO|Tobacco control country profiles. [Updated 2013; cited January 2014]. http://www.who.int/tobacco/surveillance/policy/country_profile/en/index.html</Citation>
        </Reference>
        <Reference>
          <Citation>Campaign for Tobacco Free Kids [Internet]. Legislation&#x2014;Tobacco Control Laws. [Updated January 2014; cited January 2014]. http://www.tobaccocontrollaws.org/legislation</Citation>
        </Reference>
        <Reference>
          <Citation>Smoking in Transit [Internet]. Smoking area search engine. [Updated July 2013; cited July 2012 and July 2013]. http://www.smokingtransit.com/search-airport-smoking-areas.html</Citation>
        </Reference>
        <Reference>
          <Citation>Airports Council International [Media release]. Airport service quality award winner and director general's roll of excellence inductees honoured at gala dinner. June 2013. http://www.aci.aero/News/Releases/Most-Recent/2013/06/11/Airport-Service-Quality-Award-Winners-and-Director-Generals-Roll-of-Excellence-Inductees-Honoured-at-Gala-Dinner</Citation>
        </Reference>
        <Reference>
          <Citation>Fernandez E. Spain: partial airport bans unacceptable. Tob Control 2008;17:147&#x2013;50.</Citation>
        </Reference>
        <Reference>
          <Citation>Lee K, Hahn EJ, Robertson HE, et al. Air quality in and around airport enclosed smoking rooms. Nicotine Tob Res 2010;12:665&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20410143</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wagner J, Sullivan DP, Faulkner D, et al. Environmental tobacco smoke leakage from smoking rooms. J Occup Environ Hyg 2004;1:110&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15204885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pion M, Givel MS. Airport smoking rooms don't work. Tob Control 2004;13:i37&#x2013;40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1766150</ArticleId>
            <ArticleId IdType="pubmed">14985615</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Americans for Nonsmokers&#x2019; Rights Foundation [Internet]. Smoking in Airports: Selected Tobacco Industry Documents. Sept 2001 [cited July 2013]. http://www.no-smoke.org/document.php?id=246</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">24500271</PMID>
      <DateCompleted>
        <Year>2016</Year>
        <Month>04</Month>
        <Day>04</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2015</Year>
        <Month>06</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-3318</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>24</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2015</Year>
              <Month>Jul</Month>
            </PubDate>
          </JournalIssue>
          <Title>Tobacco control</Title>
          <ISOAbbreviation>Tob Control</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Significant reduction of AECOPD hospitalisations after implementation of a public smoking ban in Graub&#xFC;nden, Switzerland.</ArticleTitle>
        <Pagination>
          <StartPage>404</StartPage>
          <EndPage>407</EndPage>
          <MedlinePgn>404-7</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/tobaccocontrol-2013-051290</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Only a few studies have examined the effect of public smoking bans on respiratory conditions. These showed reduced admission rates for different respiratory diseases.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective of the present study was to evaluate the effect of the public smoking ban implemented in Graub&#xFC;nden, Switzerland, on the incidence of acute hospital admissions for acute exacerbated chronic obstructive pulmonary disease (AECOPD).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We searched a database, including all nationwide hospitalisations in Switzerland, for AECOPD and analysed incidence rates before and after introduction of the smoking ban using Poisson regression and incidence rate ratios (IRRs).</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">After introduction of the smoking ban, we observed a significant 22.4% decrease in the incidence of AECOPD hospitalisations in Graub&#xFC;nden (IRR=0.78 (0.68 to 0.88), p&lt;0.001). In the same period, the incidence of AECOPD hospitalisations only slightly decreased by 7.0% in the rest of Switzerland (IRR=0.93 (0.91 to 0.95), p&lt;0.001). The observed reduction in AECOPD hospitalisation incidence was significantly greater in GR than in the rest of CH (p=0.008).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study supports the limited body of evidence demonstrating that a reduction of secondhand smoke by legislated bans on smoking is associated with reduced rates of admission to hospital for respiratory conditions, hereby shown for AECOPD, in addition to the meanwhile well-documented impact on cardiovascular disease.</AbstractText>
          <CopyrightInformation>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Dusemund</LastName>
            <ForeName>Frank</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Pneumology, Department of Internal Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Baty</LastName>
            <ForeName>Florent</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Pneumology, Department of Internal Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brutsche</LastName>
            <ForeName>Martin H</ForeName>
            <Initials>MH</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Pneumology, Department of Internal Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2014</Year>
          <Month>02</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Tob Control</MedlineTA>
        <NlmUniqueID>9209612</NlmUniqueID>
        <ISSNLinking>0964-4563</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
          <QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D029424" MajorTopicYN="N">Pulmonary Disease, Chronic Obstructive</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012907" MajorTopicYN="N">Smoking</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000331" MajorTopicYN="Y">legislation &amp; jurisprudence</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013557" MajorTopicYN="N" Type="Geographic">Switzerland</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Environment</Keyword>
        <Keyword MajorTopicYN="N">Global health</Keyword>
        <Keyword MajorTopicYN="N">Harm Reduction</Keyword>
        <Keyword MajorTopicYN="N">Public policy</Keyword>
        <Keyword MajorTopicYN="N">Secondhand smoke</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2013</Year>
          <Month>8</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2014</Year>
          <Month>1</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2014</Year>
          <Month>2</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2014</Year>
          <Month>2</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2016</Year>
          <Month>4</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">24500271</ArticleId>
        <ArticleId IdType="doi">10.1136/tobaccocontrol-2013-051290</ArticleId>
        <ArticleId IdType="pii">tobaccocontrol-2013-051290</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">24444512</PMID>
      <DateCompleted>
        <Year>2015</Year>
        <Month>07</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2014</Year>
        <Month>12</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1879-1026</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>505</Volume>
            <PubDate>
              <Year>2015</Year>
              <Month>Feb</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>The Science of the total environment</Title>
          <ISOAbbreviation>Sci Total Environ</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Understanding the translation of scientific knowledge about arsenic risk exposure among private well water users in Nova Scotia.</ArticleTitle>
        <Pagination>
          <StartPage>1259</StartPage>
          <EndPage>1273</EndPage>
          <MedlinePgn>1259-73</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.scitotenv.2013.12.108</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0048-9697(13)01598-2</ELocationID>
        <Abstract>
          <AbstractText>Arsenic is a class I human carcinogen that has been identified as the second most important global health concern in groundwater supplies after contamination by pathogenic organisms. Hydrogeological assessments have shown naturally occurring arsenic to be widespread in groundwater across the northeastern United States and eastern Canada. Knowledge of arsenic risk exposure among private well users in these arsenic endemic areas has not yet been fully explored but research on water quality perceptions indicates a consistent misalignment between public and scientific assessments of environmental risk. This paper evaluates knowledge of arsenic risk exposure among a demographic cross-section of well users residing in 5 areas of Nova Scotia assessed to be at variable risk (high-low) of arsenic occurrence in groundwater based on water sample analysis. An integrated knowledge-to-action (KTA) methodological approach is utilized to comprehensively assess the personal, social and local factors shaping perception of well water contaminant risks and the translation of knowledge into routine water testing behaviors. Analysis of well user survey data (n=420) reveals a high level of confidence in well water quality that is unrelated to the relative risk of arsenic exposure or homeowner adherence to government testing recommendations. Further analysis from the survey and in-depth well user interviews (n=32) finds that well users' assessments of risk are influenced by personal experience, local knowledge, social networks and convenience of infrastructure rather than by formal information channels, which are largely failing to reach their target audiences. Insights from interviews with stakeholders representing government health and environment agencies (n=15) are used to reflect on the institutional barriers that mediate the translation of scientific knowledge into public awareness and stewardship behaviors. The utilization of local knowledge brokers, community-based networks and regulatory incentives to improve risk knowledge and support routine testing among private well users is discussed.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2013 Elsevier B.V. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chappells</LastName>
            <ForeName>Heather</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Dalhousie University, Population Cancer Research Program, Department of Pediatrics, 1494 Carlton Street, P.O. Box 15000, Halifax, Nova Scotia B3H 4R2, Canada. Electronic address: h.chappells@dal.ca.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Campbell</LastName>
            <ForeName>Norma</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Dalhousie University, Population Cancer Research Program, Department of Pediatrics, 1494 Carlton Street, P.O. Box 15000, Halifax, Nova Scotia B3H 4R2, Canada. Electronic address: norma.campbell@dal.ca.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Drage</LastName>
            <ForeName>John</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Nova Scotia Department of Natural Resources, Geological Services Division, 1701 Hollis Street, Halifax, Nova Scotia B3J 2T9, Canada. Electronic address: dragejo@gov.ns.ca.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fernandez</LastName>
            <ForeName>Conrad V</ForeName>
            <Initials>CV</Initials>
            <AffiliationInfo>
              <Affiliation>Dalhousie University and IWK Health Centre, Departments of Pediatrics and Bioethics, 5850 University Avenue, Halifax, Nova Scotia B3K 6R8, Canada. Electronic address: conrad.fernandez@iwk.nshealth.ca.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Parker</LastName>
            <ForeName>Louise</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Dalhousie University, Population Cancer Research Program, Department of Pediatrics, 1494 Carlton Street, P.O. Box 15000, Halifax, Nova Scotia B3H 4R2, Canada. Electronic address: louise.parker@dal.ca.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dummer</LastName>
            <ForeName>Trevor J B</ForeName>
            <Initials>TJ</Initials>
            <AffiliationInfo>
              <Affiliation>Dalhousie University, Population Cancer Research Program, Department of Pediatrics, 1494 Carlton Street, P.O. Box 15000, Halifax, Nova Scotia B3H 4R2, Canada. Electronic address: trevor.dummer@dal.ca.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>KAL 114092</GrantID>
            <Agency>Canadian Institutes of Health Research</Agency>
            <Country>Canada</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2014</Year>
          <Month>01</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Sci Total Environ</MedlineTA>
        <NlmUniqueID>0330500</NlmUniqueID>
        <ISSNLinking>0048-9697</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014874">Water Pollutants, Chemical</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>N712M78A8G</RegistryNumber>
          <NameOfSubstance UI="D001151">Arsenic</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001151" MajorTopicYN="N">Arsenic</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004781" MajorTopicYN="N">Environmental Exposure</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D060587" MajorTopicYN="N">Groundwater</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007722" MajorTopicYN="Y">Health Knowledge, Attitudes, Practice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009511" MajorTopicYN="N" Type="Geographic">New England</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009674" MajorTopicYN="N" Type="Geographic">Nova Scotia</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014874" MajorTopicYN="N">Water Pollutants, Chemical</DescriptorName>
          <QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014881" MajorTopicYN="N">Water Supply</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D060986" MajorTopicYN="N">Water Wells</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Arsenic</Keyword>
        <Keyword MajorTopicYN="N">Drinking water</Keyword>
        <Keyword MajorTopicYN="N">Health risks</Keyword>
        <Keyword MajorTopicYN="N">Knowledge translation</Keyword>
        <Keyword MajorTopicYN="N">Private wells</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2013</Year>
          <Month>9</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2013</Year>
          <Month>12</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2013</Year>
          <Month>12</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2014</Year>
          <Month>1</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2014</Year>
          <Month>1</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2015</Year>
          <Month>7</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">24444512</ArticleId>
        <ArticleId IdType="doi">10.1016/j.scitotenv.2013.12.108</ArticleId>
        <ArticleId IdType="pii">S0048-9697(13)01598-2</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">24442884</PMID>
      <DateCompleted>
        <Year>2015</Year>
        <Month>07</Month>
        <Day>28</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2025</Year>
        <Month>02</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-2060</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>74</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2015</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Annals of the rheumatic diseases</Title>
          <ISOAbbreviation>Ann Rheum Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study.</ArticleTitle>
        <Pagination>
          <StartPage>979</StartPage>
          <EndPage>984</EndPage>
          <MedlinePgn>979-84</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/annrheumdis-2013-203993</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To compare the effectiveness of rituximab versus an alternative tumour necrosis factor (TNF) inhibitor (TNFi) in patients with rheumatoid arthritis (RA) with an inadequate response to one previous TNFi.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">SWITCH-RA was a prospective, global, observational, real-life study. Patients non-responsive or intolerant to a single TNFi were enrolled &#x2264;4&#x2005;weeks after starting rituximab or a second TNFi. Primary end point: change in Disease Activity Score in 28 joints excluding patient's global health component (DAS28-3)-erythrocyte sedimentation rate (ESR) over 6&#x2005;months.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">604 patients received rituximab, and 507 an alternative TNFi as second biological therapy. Reasons for discontinuing the first TNFi were inefficacy (n=827), intolerance (n=263) and other (n=21). A total of 728 patients were available for primary end point analysis (rituximab n=405; TNFi n=323). Baseline mean (SD) DAS28-3-ESR was higher in the rituximab than the TNFi group: 5.2 (1.2) vs 4.8 (1.3); p&lt;0.0001. Least squares mean (SE) change in DAS28-3-ESR at 6&#x2005;months was significantly greater in rituximab than TNFi patients: -1.5 (0.2) vs -1.1 (0.2); p=0.007. The difference remained significant among patients discontinuing the initial TNFi because of inefficacy (-1.7 vs -1.3; p=0.017) but not intolerance (-0.7 vs -0.7; p=0.894). Seropositive patients showed significantly greater improvements in DAS28-3-ESR with rituximab than with TNFi (-1.6 (0.3) vs -1.2 (0.3); p=0.011), particularly those switching because of inefficacy (-1.9 (0.3) vs -1.5 (0.4); p=0.021). The overall incidence of adverse events was similar between the rituximab and TNFi groups.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These real-life data indicate that, after discontinuation of an initial TNFi, switching to rituximab is associated with significantly improved clinical effectiveness compared with switching to a second TNFi. This difference was particularly evident in seropositive patients and in those switched because of inefficacy.</AbstractText>
          <CopyrightInformation>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Emery</LastName>
            <ForeName>P</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gottenberg</LastName>
            <ForeName>J E</ForeName>
            <Initials>JE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, CHU Strasbourg, Strasbourg, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rubbert-Roth</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>University of Cologne, Cologne, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sarzi-Puttini</LastName>
            <ForeName>P</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>L Sacco University Hospital, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Choquette</LastName>
            <ForeName>D</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>University of Montreal, Montreal, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Taboada</LastName>
            <ForeName>V M Mart&#xED;nez</ForeName>
            <Initials>VM</Initials>
            <AffiliationInfo>
              <Affiliation>Facultad de Medicina, Hospital Universitario Marqu&#xE9;s de Valdecilla, Universidad de Cantabria, Santander, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Barile-Fabris</LastName>
            <ForeName>L</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Hospital de Especialidades Centro M&#xE9;dico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, M&#xE9;xico City, Mexico.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moots</LastName>
            <ForeName>R J</ForeName>
            <Initials>RJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, University of Liverpool, Liverpool, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ostor</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Andrianakos</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Hellenic Foundation for Rheumatological Research, Athens, Greece.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gemmen</LastName>
            <ForeName>E</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Quintiles, Rockville, Maryland, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mpofu</LastName>
            <ForeName>C</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>F Hoffmann-La Roche Ltd, Basel, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chung</LastName>
            <ForeName>C</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Genentech Inc, San Francisco, California, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gylvin</LastName>
            <ForeName>L Hinsch</ForeName>
            <Initials>LH</Initials>
            <AffiliationInfo>
              <Affiliation>F Hoffmann-La Roche Ltd, Basel, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Finckh</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>University Hospital of Geneva, Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>18475</GrantID>
            <Acronym>ARC_</Acronym>
            <Agency>Arthritis Research UK</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>18475</GrantID>
            <Acronym>VAC_</Acronym>
            <Agency>Versus Arthritis</Agency>
            <Country>United Kingdom</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D003160">Comparative Study</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D064888">Observational Study</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2014</Year>
          <Month>01</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Ann Rheum Dis</MedlineTA>
        <NlmUniqueID>0372355</NlmUniqueID>
        <ISSNLinking>0003-4967</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D058846">Antibodies, Monoclonal, Murine-Derived</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018501">Antirheumatic Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>4F4X42SYQ6</RegistryNumber>
          <NameOfSubstance UI="D000069283">Rituximab</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>YL5FZ2Y5U1</RegistryNumber>
          <NameOfSubstance UI="D008727">Methotrexate</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058846" MajorTopicYN="N">Antibodies, Monoclonal, Murine-Derived</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018501" MajorTopicYN="N">Antirheumatic Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057915" MajorTopicYN="N">Drug Substitution</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008727" MajorTopicYN="N">Methotrexate</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000069283" MajorTopicYN="N">Rituximab</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017211" MajorTopicYN="N">Treatment Failure</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName>
          <QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Anti-TNF</Keyword>
        <Keyword MajorTopicYN="N">B cells</Keyword>
        <Keyword MajorTopicYN="N">DMARDs (biologic)</Keyword>
        <Keyword MajorTopicYN="N">Rheumatoid Arthritis</Keyword>
        <Keyword MajorTopicYN="N">Treatment</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2013</Year>
          <Month>5</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2013</Year>
          <Month>12</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2014</Year>
          <Month>1</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2014</Year>
          <Month>1</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2015</Year>
          <Month>7</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2015</Year>
          <Month>5</Month>
          <Day>14</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">24442884</ArticleId>
        <ArticleId IdType="pmc">PMC4431330</ArticleId>
        <ArticleId IdType="doi">10.1136/annrheumdis-2013-203993</ArticleId>
        <ArticleId IdType="pii">S0003-4967(24)02669-4</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Mewar D, Wilson AG. Treatment of rheumatoid arthritis with tumour necrosis factor inhibitors. Br J Pharmacol 2011;162:785&#x2013;91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3042190</ArticleId>
            <ArticleId IdType="pubmed">21039421</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rubbert-Roth A, Finckh A. Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review. Arthritis Res Ther 2009;11(Suppl 1):S1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2669237</ArticleId>
            <ArticleId IdType="pubmed">19368701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smolen JS, Kay J, Doyle MK, et al. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial. Lancet 2009;374:210&#x2013;21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19560810</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buch MH, Bingham SJ, Bejarano V, et al. Therapy of patients with rheumatoid arthritis: outcome of infliximab failures switched to etanercept. Arthritis Rheum 2007;57:448&#x2013;53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17394231</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gomez-Reino JJ, Carmona L. Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period. Arthritis Res Ther 2006;8:R29.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1526564</ArticleId>
            <ArticleId IdType="pubmed">16507128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wick MC, Ernestam S, Lindblad S, et al. Adalimumab (Humira&#xAE;) restores clinical response in patients with secondary loss of efficacy from infliximab (Remicade&#xAE;) or etanercept (Enbrel&#xAE;): results from the STURE registry at Karolinska University Hospital. Scand J Rheumatol 2005;34:353&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16234182</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haraoui B, Keystone EC, Thorne JC, et al. Clinical outcomes of patients with rheumatoid arthritis after switching from infliximab to etanercept. J Rheumatol 2004;31:2356&#x2013;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15570634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cohen SB, Emery P, Greenwald MW, et al. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum 2006;54:2793&#x2013;806.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16947627</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Emery P, Keystone E, Tony HP, et al. IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial. Ann Rheum Dis 2008;67:1516&#x2013;23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3811149</ArticleId>
            <ArticleId IdType="pubmed">18625622</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Genovese MC, Becker JC, Schiff M, et al. Abatacept for rheumatoid arthritis refractory to tumor necrosis factor &#x3B1; inhibition. N Engl J Med 2005;353:1114&#x2013;23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16162882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salliot C, Finckh A, Katchamart W, et al. Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis. Ann Rheum Dis 2011;70:266&#x2013;71.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21097801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moots RJ, Naisbett-Groet B. The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors: a systematic review. Rheumatology (Oxford) 2012;51:2252&#x2013;61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22942404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schoels M, Aletaha D, Smolen JS, et al. Comparative effectiveness and safety of biological treatment options after tumour necrosis factor alpha inhibitor failure in rheumatoid arthritis: systematic review and indirect pairwise meta-analysis. Ann Rheum Dis 2012;71:1303&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22294630</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malottki K, Barton P, Tsourapas A, et al. Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation. Health Technol Assess 2011;15:1&#x2013;278.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4781257</ArticleId>
            <ArticleId IdType="pubmed">21439251</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gomez-Reino JJ, Maneiro JR, Ruiz J, et al. Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists: the MIRAR Study. Ann Rheum Dis 2012;71:1861&#x2013;4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22736086</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finckh A, Ciurea A, Brulhart L, et al. Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent? Ann Rheum Dis 2010;69:387&#x2013;93.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2800201</ArticleId>
            <ArticleId IdType="pubmed">19416802</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finckh A, Ciurea A, Brulhart L, et al. B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents. Arthritis Rheum 2007;56:1417&#x2013;23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17469098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Madsen OR. Is DAS28-CRP with three and four variables interchangeable in individual patients selected for biological treatment in daily clinical practice? Clin Rheumatol 2011;30:1577&#x2013;82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21956233</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prevoo ML, van't Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7818570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DAS28. http://www.das28.nl/das28/en/difference-between-the-das-and-das28/how-to-measure-the-das28/how-to-calculate-the-das28.html (accessed 3 Apr 2013).</Citation>
        </Reference>
        <Reference>
          <Citation>Lutt JR, Deodhar A. Rheumatoid arthritis: strategies in the management of patients showing an inadequate response to TNFalpha antagonists. Drugs 2008;68:591&#x2013;606.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18370440</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buch MH. Sequential use of biologic therapy in rheumatoid arthritis. Curr Opin Rheumatol 2010;22:321&#x2013;9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20190641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soliman MM, Hyrich KL, Lunt M, et al. Rituximab or a second anti-tumor necrosis factor therapy for rheumatoid arthritis patients who have failed their first anti-tumor necrosis factor therapy? Comparative analysis from the British Society for Rheumatology Biologics Register. Arthritis Care Res (Hoboken) 2012;64:1108&#x2013;15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3492906</ArticleId>
            <ArticleId IdType="pubmed">22422731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finckh A, Moller B, Dudler J, et al. Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists. Ann Rheum Dis 2012;71:1680&#x2013;5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3500530</ArticleId>
            <ArticleId IdType="pubmed">22419773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Virkki LM, Valleala H, Takakubo Y, et al. Outcomes of switching anti-TNF drugs in rheumatoid arthritis&#x2014;a study based on observational data from the Finnish Register of Biological Treatment (ROB-FIN). Clin Rheumatol 2011;30:1447&#x2013;54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21644062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Remy A, Avouac J, Gossec L, et al. Clinical relevance of switching to a second tumour necrosis factor-alpha inhibitor after discontinuation of a first tumour necrosis factor-alpha inhibitor in rheumatoid arthritis: a systematic literature review and meta-analysis. Clin Exp Rheumatol 2011;29:96&#x2013;103.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21269578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Solau-Gervais E, Prudhomme C, Philippe P, et al. Efficacy of rituximab in the treatment of rheumatoid arthritis. Influence of serologic status, coprescription of methotrexate and prior TNF-alpha inhibitors exposure. Joint Bone Spine 2012;79:281&#x2013;4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21724444</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Isaacs JD, Cohen SB, Emery P, et al. Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis. Ann Rheum Dis 2013;72:329&#x2013;36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22689315</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chatzidionysiou K, Lie E, Nasonov E, et al. Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries. Ann Rheum Dis 2011;70:1575&#x2013;80.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21571731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sellam J, Hendel-Chavez H, Rouanet S, et al. B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: a six-month, national, multicenter, open-label study. Arthritis Rheum 2011;63:933&#x2013;8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21225699</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klaasen R, Cantaert T, Wijbrandts CA, et al. The value of rheumatoid factor and anti-citrullinated protein antibodies as predictors of response to infliximab in rheumatoid arthritis: an exploratory study. Rheumatology (Oxford) 2011;50:1487&#x2013;93.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21454308</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cuchacovich M, Catalan D, Wainstein E, et al. Basal anti-cyclic citrullinated peptide (anti-CCP) antibody levels and a decrease in anti-CCP titres are associated with clinical response to adalimumab in rheumatoid arthritis. Clin Exp Rheumatol 2008;26:1067&#x2013;73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19210871</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bobbio-Pallavicini F, Caporali R, Alpini C, et al. High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor &#x3B1; inhibitors in rheumatoid arthritis. Ann Rheum Dis 2007;66:302&#x2013;7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1856018</ArticleId>
            <ArticleId IdType="pubmed">17079248</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Potter C, Hyrich KL, Tracey A, et al. Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis. Ann Rheum Dis 2009;68:69&#x2013;74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2596303</ArticleId>
            <ArticleId IdType="pubmed">18375541</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">24373050</PMID>
      <DateCompleted>
        <Year>2015</Year>
        <Month>12</Month>
        <Day>04</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2024</Year>
        <Month>03</Month>
        <Day>22</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1471-8847</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>15</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2015</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Developing world bioethics</Title>
          <ISOAbbreviation>Dev World Bioeth</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Cultural conundrums: the ethics of epidemiology and the problems of population in implementing pre-exposure prophylaxis.</ArticleTitle>
        <Pagination>
          <StartPage>27</StartPage>
          <EndPage>39</EndPage>
          <MedlinePgn>27-39</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/dewb.12034</ELocationID>
        <Abstract>
          <AbstractText>The impending implementation of pre-exposure prophylaxis (PrEP) has prompted complicated bioethical and public health ethics concerns regarding the moral distribution of antiretroviral medications (ARVs) to ostensibly healthy populations as a form of HIV prevention when millions of HIV-positive people still lack access to ARVs globally. This manuscript argues that these questions are, in part, concerns over the ethics of the knowledge production practices of epidemiology. Questions of distribution, and their attendant cost-benefit calculations, will rely on a number of presupposed, and therefore, normatively cultural assumptions within the science of epidemiology specifically regarding the ability of epidemiologic surveillance to produce accurate maps of HIV throughout national populations. Specifically, ethical questions around PrEP will focus on who should receive ARVs given the fact that global demand will far exceed supply. Given that sexual transmission is one of the main modes of HIV transmission, these questions of 'who' are inextricably linked to knowledge about sexual personhood. As a result, the ethics of epidemiology, and how the epidemiology of HIV in particular conceives, classifies and constructs sexual populations will become a critical point of reflection and contestation for bioethicists, health activists, physicians, nurses, and researchers in the multi-disciplinary field of global health. This paper examines how cultural conundrums within the fields of bioethics and public health ethics are directly implicated within the ethics of PrEP, by analyzing the problems of population inaugurated by the construction of the men who have sex with men (MSM) epidemiologic category in the specific national context of South Africa.</AbstractText>
          <CopyrightInformation>&#xA9; 2013 John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Fiereck</LastName>
            <ForeName>Kirk</ForeName>
            <Initials>K</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>F31 MH088943</GrantID>
            <Acronym>MH</Acronym>
            <Agency>NIMH NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2013</Year>
          <Month>12</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Dev World Bioeth</MedlineTA>
        <NlmUniqueID>101120122</NlmUniqueID>
        <ISSNLinking>1471-8731</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D019380">Anti-HIV Agents</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D019380" MajorTopicYN="N">Anti-HIV Agents</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003466" MajorTopicYN="Y">Cultural Characteristics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004813" MajorTopicYN="N">Epidemiology</DescriptorName>
          <QualifierName UI="Q000941" MajorTopicYN="N">ethics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018451" MajorTopicYN="Y">Homosexuality, Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009014" MajorTopicYN="N">Morals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D065129" MajorTopicYN="N">Pre-Exposure Prophylaxis</DescriptorName>
          <QualifierName UI="Q000941" MajorTopicYN="Y">ethics</QualifierName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName>
          <QualifierName UI="Q000941" MajorTopicYN="Y">ethics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013019" MajorTopicYN="N" Type="Geographic">South Africa</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D047568" MajorTopicYN="Y">Unsafe Sex</DescriptorName>
          <QualifierName UI="Q000941" MajorTopicYN="N">ethics</QualifierName>
          <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Bioethics</Keyword>
        <Keyword MajorTopicYN="N">Culture</Keyword>
        <Keyword MajorTopicYN="N">Ethnography</Keyword>
        <Keyword MajorTopicYN="N">MSM</Keyword>
        <Keyword MajorTopicYN="N">Pre-Exposure Prophylaxis</Keyword>
        <Keyword MajorTopicYN="N">Public Health Ethics</Keyword>
        <Keyword MajorTopicYN="N">Social Epidemiology</Keyword>
        <Keyword MajorTopicYN="N">South Africa</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2013</Year>
          <Month>12</Month>
          <Day>31</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2014</Year>
          <Month>1</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2015</Year>
          <Month>12</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2016</Year>
          <Month>4</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">24373050</ArticleId>
        <ArticleId IdType="mid">NIHMS494693</ArticleId>
        <ArticleId IdType="pmc">PMC4067472</ArticleId>
        <ArticleId IdType="doi">10.1111/dewb.12034</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Rosengarten M, Michael M. The Performative Function of Expectations in Translating Treatment to Prevention: The Case of HIV Pre-Exposure Prophylaxis, or PrEP. Social Science &amp; Medicine. 2009;69(7):1049&#x2013;55.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19695756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosengarten M, Michael M. Rethinking the Bioethical Enactment of Medically Drugged Bodies: Paradoxes of Using Anti-HIV Drug Therapy as a Technology for Prevention. Science as Culture. 2009;18(2):183&#x2013;99.</Citation>
        </Reference>
        <Reference>
          <Citation>Mills EJ, et al. Designing research in vulnerable populations: Lessons from HIV prevention trials that stopped early. British Medical Journal. 2005;331(7529):1403&#x2013;06.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1309660</ArticleId>
            <ArticleId IdType="pubmed">16339256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mills, et al. op cit. :1403. note 3.</Citation>
        </Reference>
        <Reference>
          <Citation>Mills, et al. op cit. :1403. note 3.</Citation>
        </Reference>
        <Reference>
          <Citation>Rosengarten, Michael op cit. :196. note 3.</Citation>
        </Reference>
        <Reference>
          <Citation>Van Damme L, et al.  Preexposure Prophylaxis for HIV Infection among African Women. New England Journal of Medicine. 2012  http://dx.doi.org/10.1056/NEJMoa1202614.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1202614</ArticleId>
            <ArticleId IdType="pmc">PMC3687217</ArticleId>
            <ArticleId IdType="pubmed">22784040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peterson L, et al.  Tenofovir Disoproxil Fumarate for Prevention of HIV Infection in Women: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Trial. PLOS Clin Trial. 2007;2(5):e27.  http://dx.plos.org/10.1371%2Fjournal.pctr.0020027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1876601</ArticleId>
            <ArticleId IdType="pubmed">17525796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baeten JM, et al.  Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women. New England Journal of Medicine. 2012  http://dx.doi.org/10.1056/NEJMoa1108524.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1108524</ArticleId>
            <ArticleId IdType="pmc">PMC3770474</ArticleId>
            <ArticleId IdType="pubmed">22784037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thigpen MC, et al.  Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana. New England Journal of Medicine. 2012  http://dx.doi.org/10.1056/NEJMoa1110711.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1110711</ArticleId>
            <ArticleId IdType="pubmed">22784038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grant RM, et al.  Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men. New England Journal of Medicine. 2010  http://dx.doi.org/10.1056/NEJMoa1011205.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1011205</ArticleId>
            <ArticleId IdType="pmc">PMC3079639</ArticleId>
            <ArticleId IdType="pubmed">21091279</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Food and Drug Administration. FDA approves first drug for reducing the risk of sexually acquired HIV infection. Washington, DC: FDA; 2012.</Citation>
        </Reference>
        <Reference>
          <Citation>Page-Shafer K, et al. HIV prevention research in a resource-limited setting: the experience of planning a trial in Cambodia. The Lancet. 2005;366(9495):1499&#x2013;503.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16243095</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grant RM, et al. AIDS: promote HIV chemoprophylaxis research, don&#x2019;t prevent it. Science. 2005 Sep 30;:2170&#x2013;71.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16195446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosengarten, Michael op cit. :192&#x2013;194. note 3.</Citation>
        </Reference>
        <Reference>
          <Citation>Rosengarten, Michael op cit. :1054. note 1.</Citation>
        </Reference>
        <Reference>
          <Citation>Mol A. The Body Multiple: Ontology in Medical Practice. Durham: Duke University Press; 2003.</Citation>
        </Reference>
        <Reference>
          <Citation>Rosengarten, Michael op cit. :193. note 3.</Citation>
        </Reference>
        <Reference>
          <Citation>Patton C, Kim HJ. The cost of science: Knowledge and ethics in the HIV pre-exposure prophylaxis trials. Bioethical Inquiry. 2012;9:295&#x2013;310.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23180330</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krieger N. A Glossary for Social Epidemiology. Journal of Epidemiology of Community Health. 2001;55:693&#x2013;700.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1731785</ArticleId>
            <ArticleId IdType="pubmed">11553651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marmot M. Achieving Health Equity: From Root Causes to Fair Outcomes. Lancet. 2007;370:1153&#x2013;63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17905168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Link BG, Phelen J. Social conditions as fundamental causes of disease. Journal of Health and Social Behavior. 1995;35:80&#x2013;94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7560851</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berkman LF, Kawachi I. Social Epidemiology. New York: Oxford University Press; 2000.</Citation>
        </Reference>
        <Reference>
          <Citation>Marmot M, Wilkinson RG, editors. Social Determinants of Health. 2. Oxford: Oxford University Press; 2006.</Citation>
        </Reference>
        <Reference>
          <Citation>Brunner E, et al. Social Epidemiology and Eastern Wisdom. Journal of Epidemiology. 2012;22(4):291&#x2013;4. 293.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3798646</ArticleId>
            <ArticleId IdType="pubmed">22790787</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DiGiacomo SM. Can there be a &#x201C;cultural epidemiology&#x201D;? Medical Anthropology Quarterly. 1999;13(4):436&#x2013;57. 446.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10626275</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galison P. Introduction: The Context of Disunity. In: Galison P, Stump DJ, editors. The Disunity of Science: Boundaries, Contexts, and Power. Stanford, CA.: Stanford University Press; 1996. pp. 1&#x2013;36.</Citation>
        </Reference>
        <Reference>
          <Citation>Trostle JA, Sommerfeld J. Medical anthropology and epidemiology. Annual Review of Anthropology. 1996;25:253&#x2013;74.</Citation>
        </Reference>
        <Reference>
          <Citation>Fairchild AL, Bayer R. Ethics and the conduct of public health surveillance. Science. 2004 Jan 30;303:631&#x2013;32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14752148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kass N. An ethics framework for public health. Public Health Matters. 2001;91(11):1776&#x2013;83.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1446875</ArticleId>
            <ArticleId IdType="pubmed">11684600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Childress JF, et al. Public health ethics: Mapping the terrain. Journal of Law, Medicine and Ethics. 2002;30:170&#x2013;78.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12066595</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DiGiacomo op cit. note 26.</Citation>
        </Reference>
        <Reference>
          <Citation>Trostle, Sommerfeld op cit. note 28.</Citation>
        </Reference>
        <Reference>
          <Citation>Das V. Public Good, Ethics, and Everyday Life: Beyond the Boundaries of Bioethics. Daedalus. 1999;128(4):99&#x2013;133.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11645883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Philpott S. Social justice, public health ethics, and the use of pre-exposure prophylaxis. American Journal of Preventive Medicine. 2013;44(1S2):S137&#x2013;S40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23253755</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kass op cit. :1777. note 30.</Citation>
        </Reference>
        <Reference>
          <Citation>Powers M, Faden R. Social Justice : The Moral Foundations of Public Health and Health Policy. Cary, NC: Oxford University Press; 2008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18259708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gostin LO, Powers M. What does social justice require for the public&#x2019;s health? Public health ethics and policy imperatives. Health Affairs. 2006;25(4):1053&#x2013;60.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16835186</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biehl J. Pharmaceuticalization: AIDS treatment and global health politics. Anthropological Quarterly. 2007;80(4):1083&#x2013;126.</Citation>
        </Reference>
        <Reference>
          <Citation>Petryna A. Ethical Variability: Drug Development and Globalizing Clinical Trials. American Ethnologist. 2005;32(2):183&#x2013;97. 184.</Citation>
        </Reference>
        <Reference>
          <Citation>Biehl J. Technology and Affect: HIV/AIDS Testing in Brazil. Culture, Medicine and Psychiatry. 2001;25(1):87&#x2013;129.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11270667</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kleinman A. Moral Experience and Ethical Reflection: Can Ethnography Reconcile Them? A Quandary for &#x201C;The New Bioethics&#x201D;. Daedalus. 1999;128(4):69&#x2013;97.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11645882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sunder Rajan K. Experimental Values: Indian Clinical Trials and Surplus Health. New Left Review. 2007 May-Jun;45:67&#x2013;88.</Citation>
        </Reference>
        <Reference>
          <Citation>Marshall PA. Anthropology and bioethics. Medical Anthropology Quarterly. 1992;6(1):49&#x2013;73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11659464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kleinman A, Benson P. Anthropology in the clinic: The problem of cultural competency and how to fix it. PLoS Medicine. 2006;3(10):1673&#x2013;76.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1621088</ArticleId>
            <ArticleId IdType="pubmed">17076546</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taylor JS. Confronting &#x201C;culture&#x201D; in medicine&#x2019;s &#x201C;culture of no culture&#x201D;. Academic Medicine. 2003;78(6):555&#x2013;59.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12805033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brada B. &#x201C;Not here&#x201D;: Making the spaces and subjects of &#x201C;global health&#x201D; in Botswana. Culture, Medicine and Psychiatry. 2011;35:285&#x2013;312.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21614625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Foucault M. On the Geneaology of Ethics: An Overview of a Work in Progress. Ethics: Subjectivity and Truth 1997</Citation>
        </Reference>
        <Reference>
          <Citation>Rabinow P, editor. Essential Works of Foucault 1954-1984. New York: The New Press; pp. 253&#x2013;80.pp. 263</Citation>
        </Reference>
        <Reference>
          <Citation>Karkazis K, et al. Out of bounds? A critique of the new policies on hyperandrogenism in elite female athletes. The American Journal of Bioethics. 2012;12(7):3&#x2013;16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5152729</ArticleId>
            <ArticleId IdType="pubmed">22694023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boellstorff T. But Do Not Identify as Gay: A Proleptic Genealogy of the MSM Category. Cultural Anthropology. 2011;26(2):287&#x2013;312.</Citation>
        </Reference>
        <Reference>
          <Citation>Traweek S. Beamtimes and Lifetimes: The World of High Energy Physicists. Cambridge, MA: Harvard University Press; 1988.</Citation>
        </Reference>
        <Reference>
          <Citation>Taylor op cit. note 43.</Citation>
        </Reference>
        <Reference>
          <Citation>Parker R. Bodies, Pleasures and Passions: Sexual Culture in Contemporary Brazil. Nashville: Vanderbilt University Press; 2009.</Citation>
        </Reference>
        <Reference>
          <Citation>Donham DL. Freeing South Africa: The &#x201C;modernization&#x201D; of male-male sexuality in Soweto. Cultural Anthropology. 1998;13(1):3&#x2013;21.</Citation>
        </Reference>
        <Reference>
          <Citation>Boellstorff T. The Gay Archipelago: Sexuality and Nation in Indonesia. Princeton: Princeton University Press; 2005.</Citation>
        </Reference>
        <Reference>
          <Citation>Baral S, et al. HIV Risk and Associations of HIV Infection among Men who have Sex with Men in Peri-Urban Cape Town, South Africa. BMC Public Health. 2011;11:766&#x2013;73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3196714</ArticleId>
            <ArticleId IdType="pubmed">21975248</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rispel LC, et al. HIV Prevalence and Risk Practices Among Men Who Have Sex With Men in Two South African Cities. J Acquir Immune Defic Syndr. 2011;57(1):69&#x2013;76.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21297480</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lane T, et al. High HIV Prevalence among Men who have Sex with Men in Soweto, South Africa: Results from the Soweto Men&#x2019;s Study. AIDS Behavior. 2009;15(3):626&#x2013;34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2888758</ArticleId>
            <ArticleId IdType="pubmed">19662523</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gevisser M, Cameron E. Defiant Desire: Gay and Lesbian Lives in South Africa. Braamfontein: Ravan Press; 1994.</Citation>
        </Reference>
        <Reference>
          <Citation>Krouse M, editor. The Invisible Ghetto: Lesbian and Gay Writing From South Africa. London: The Gay Men&#x2019;s Press; 1993.</Citation>
        </Reference>
        <Reference>
          <Citation>Butler J. Bodies that Matter: On the Discursive Limits of Sex. New York: Routledge; 1993.</Citation>
        </Reference>
        <Reference>
          <Citation>Laqueur T. Making Sex: Body and Gender from the Greeks to Freud. Cambridge, MA and London: Harvard University Press; 1990.</Citation>
        </Reference>
        <Reference>
          <Citation>Mahajan M. Designing Epidemics: Models, Policy-making, and Global Foreknowledge in India&#x2019;s AIDS Epidemic. Science and Public Policy. 2008;35(8):585&#x2013;96. 592.</Citation>
        </Reference>
        <Reference>
          <Citation>Bekker L-G, et al. Southern African Guidelines for the Safe Use of Pre-Exposure Prophylaxis in Men who have Sex with Men who are at Risk for HIV Infection. Southern African Journal of HIV Medicine. 2012;13(2):40&#x2013;55.</Citation>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control. Interim Guidance: Preexposure Prophylaxis for the Prevention of HIV Infection in Men Who Have Sex with Men. Morbidity and Mortality Weekly Report. 2011;60(3):65&#x2013;68.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21270743</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baral, et al. op cit. note 53.</Citation>
        </Reference>
        <Reference>
          <Citation>Lane, et al. op cit. note 53.</Citation>
        </Reference>
        <Reference>
          <Citation>Rispel, et al. op cit. note 53.</Citation>
        </Reference>
        <Reference>
          <Citation>Baral, et al. op cit. note 53.</Citation>
        </Reference>
        <Reference>
          <Citation>Baral, et al. op cit. note 53.</Citation>
        </Reference>
        <Reference>
          <Citation>Lane, et al. op cit. note 53.</Citation>
        </Reference>
        <Reference>
          <Citation>Rispel, et al. op cit. note 53.</Citation>
        </Reference>
        <Reference>
          <Citation>Mahajan op cit. note 56.</Citation>
        </Reference>
        <Reference>
          <Citation>Reid G. &#x2018;This Thing&#x2019; and &#x2018;That Idea&#x2019;: Traditionalist Responses to Homosexuality and Same-Sex Marriage. In: Judge M, Manion A, de Waal S, editors. To Have and To Hold: The Making of Same-Sex Marriage in South Africa. Johannesburg: Jacana Media; 2008. pp. 73&#x2013;86.</Citation>
        </Reference>
        <Reference>
          <Citation>Reid G. How to be a &#x2018;Real&#x2019; Gay: Emerging Gay Spaces in Small-Town South Africa University of Amsterdam 2003</Citation>
        </Reference>
        <Reference>
          <Citation>Donham op cit. :7. note 52.</Citation>
        </Reference>
        <Reference>
          <Citation>McLean H, Ngcobo L. Abangibhamayo Bathi Ngimanandi (Those Who Fuck Me Say I&#x2019;m Tasty): Gay Sexuality In Reef Townships. In: Gevisser M, Cameron E, editors. Defiant Desire: Gay and Lesbian lives in South Africa. Braamfontein: Ravan Press; 1994. pp. 158&#x2013;85.pp. 168&#x2013;169.</Citation>
        </Reference>
        <Reference>
          <Citation>Chauncey G. Gay New York: Gender, Urban Culture, and the Making of the Gay Male World, 1890-1940. New York: Basic Books; 1994.</Citation>
        </Reference>
        <Reference>
          <Citation>Lane, et al. op cit. note 53.</Citation>
        </Reference>
        <Reference>
          <Citation>Shisana O, et al. South African National HIV Prevalence, Incidence, Behaviour and Communication Survey 2008: A Turning Tide among Teenagers? Cape Town: HSRC Press; 2009.</Citation>
        </Reference>
        <Reference>
          <Citation>Pretorious C, et al. Evaluating the Cost-Effectiveness of Pre-Exposure Prophylaxis (PrEP) and Its Impact on HIV-1 Transmission in South Africa. PLoSOne. 2010;5:11. doi: 10.1371/journal.pone.0013646.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0013646</ArticleId>
            <ArticleId IdType="pmc">PMC2974638</ArticleId>
            <ArticleId IdType="pubmed">21079767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bor J, et al. Increases in adult life expectancy in rural South Africa: Valuing the scale-up of HIV treatment. Science. 2013;339:961&#x2013;65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3860268</ArticleId>
            <ArticleId IdType="pubmed">23430655</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tanser F, et al. High coverage of ART associated with cecline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science. 2013;339:966&#x2013;71.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4255272</ArticleId>
            <ArticleId IdType="pubmed">23430656</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bor, et al. op cit. note 78.</Citation>
        </Reference>
        <Reference>
          <Citation>Boellstorff op cit. note 52.</Citation>
        </Reference>
        <Reference>
          <Citation>Boellstorff T. The Gay Archipelago: Sexuality and Nation in Indonesia</Citation>
        </Reference>
        <Reference>
          <Citation>Cohen L. The Kothi Wars: AIDS Cosmopolitanism and the Morality of Classification. In: Adams V, Pigg SL, editors. Sex in Development: Science, Sexuality and Morality in Global Perspective. Durham, NC: Duke University Press; 2005. pp. 269&#x2013;303.</Citation>
        </Reference>
        <Reference>
          <Citation>Morris R. Three sexes and four sexualities: Redressing the discourses on gender and sexuality in contemporary Thailand. Positions. 1994;2(1):15&#x2013;43.</Citation>
        </Reference>
        <Reference>
          <Citation>Parker op cit. note 52.</Citation>
        </Reference>
        <Reference>
          <Citation>Biehl op cit. note 39.</Citation>
        </Reference>
        <Reference>
          <Citation>Parker F. Drug patent war threatens SA healthcare. Mail and Guardian Online. 2012 Jul 12;</Citation>
        </Reference>
        <Reference>
          <Citation>Patton, Kim op cit. 304 note 17.</Citation>
        </Reference>
        <Reference>
          <Citation>Rosengarten, Michael op cit. note 1.</Citation>
        </Reference>
        <Reference>
          <Citation>Young RM, Meyer IH. The Trouble with &#x201C;MSM&#x201D; and &#x201C;WSW&#x201D;: Erasure of the Sexual-Minority Person in Public Health Discourse. American Journal of Public Health. 2005;95(7):1144&#x2013;49.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1449332</ArticleId>
            <ArticleId IdType="pubmed">15961753</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">24335477</PMID>
      <DateCompleted>
        <Year>2016</Year>
        <Month>02</Month>
        <Day>22</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-3318</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>24</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2015</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Tobacco control</Title>
          <ISOAbbreviation>Tob Control</ISOAbbreviation>
        </Journal>
        <ArticleTitle>I 'like' MPOWER: using Facebook, online ads and new media to mobilise tobacco control communities in low-income and middle-income countries.</ArticleTitle>
        <Pagination>
          <StartPage>306</StartPage>
          <EndPage>312</EndPage>
          <MedlinePgn>306-12</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/tobaccocontrol-2012-050946</ELocationID>
        <Abstract>
          <AbstractText>New media campaigns hold great potential to grow public awareness about the dangers of tobacco use and advance tobacco control policies, including in low-income and middle-income countries (LMICs), which have shared in a decade of explosive growth in mobile and internet penetration. With the majority of deaths from the tobacco epidemic occurring in LMICs, new media must be harnessed both as an advocacy tool to promote social mobilisation around tobacco issues and to build public support for MPOWER policies. This paper examines three consecutive new media advocacy campaigns that used communication channels such as mobile SMS, Facebook and online advertising to promote tobacco control policies. It includes some of the lessons learned, such as the pitfalls of relying on viral growth as a strategy for obtaining reach and campaign growth; the challenge of translating strategies from traditional media to new media; and the importance of incorporating marketing strategies such as paid advertising, community organising or public relations. It also identifies some of the many knowledge gaps and proposes future research directions.</AbstractText>
          <CopyrightInformation>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hamill</LastName>
            <ForeName>Stephen</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>World Lung Foundation, New York, New York, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Turk</LastName>
            <ForeName>Tahir</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>World Lung Foundation, New York, New York, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Murukutla</LastName>
            <ForeName>Nandita</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>World Lung Foundation, New York, New York, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ghamrawy</LastName>
            <ForeName>Mohamed</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Freelance Designer, Cairo, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mullin</LastName>
            <ForeName>Sandra</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>World Lung Foundation, New York, New York, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2013</Year>
          <Month>12</Month>
          <Day>13</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Tob Control</MedlineTA>
        <NlmUniqueID>9209612</NlmUniqueID>
        <ISSNLinking>0964-4563</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000329" MajorTopicYN="Y">Advertising</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003254" MajorTopicYN="N">Consumer Advocacy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006293" MajorTopicYN="N">Health Promotion</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011203" MajorTopicYN="Y">Poverty</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016540" MajorTopicYN="N">Smoking Cessation</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012923" MajorTopicYN="Y">Social Class</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D061108" MajorTopicYN="N">Social Media</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Advocacy</Keyword>
        <Keyword MajorTopicYN="N">Global Health</Keyword>
        <Keyword MajorTopicYN="N">Low/Middle Income Country</Keyword>
        <Keyword MajorTopicYN="N">Media</Keyword>
        <Keyword MajorTopicYN="N">Social Marketing</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2013</Year>
          <Month>1</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2013</Year>
          <Month>11</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2013</Year>
          <Month>12</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2013</Year>
          <Month>12</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2016</Year>
          <Month>2</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">24335477</ArticleId>
        <ArticleId IdType="doi">10.1136/tobaccocontrol-2012-050946</ArticleId>
        <ArticleId IdType="pii">tobaccocontrol-2012-050946</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">24333545</PMID>
      <DateCompleted>
        <Year>2016</Year>
        <Month>01</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1873-6254</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>141</Volume>
            <Issue>Pt B</Issue>
            <PubDate>
              <Year>2015</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Acta tropica</Title>
          <ISOAbbreviation>Acta Trop</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Health metrics for helminth infections.</ArticleTitle>
        <Pagination>
          <StartPage>150</StartPage>
          <EndPage>160</EndPage>
          <MedlinePgn>150-60</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actatropica.2013.12.001</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0001-706X(13)00350-1</ELocationID>
        <Abstract>
          <AbstractText>Health metrics based on health-adjusted life years have become standard units for comparing the disease burden and treatment benefits of individual health conditions. The Disability-Adjusted Life Year (DALY) and the Quality-Adjusted Life Year (QALY) are the most frequently used in cost-effect analyses in national and global health policy discussions for allocation of health care resources. While sometimes useful, both the DALY and QALY metrics have limitations in their ability to capture the full health impact of helminth infections and other 'neglected tropical diseases' (NTDs). Gaps in current knowledge of disease burden are identified, and interim approaches to disease burden assessment are discussed.</AbstractText>
          <CopyrightInformation>Copyright &#xA9; 2013 Elsevier B.V. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>King</LastName>
            <ForeName>Charles H</ForeName>
            <Initials>CH</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Global Health and Diseases, Case Western Reserve University School of Medicine, 2109 Adelbert Road, BRB Room 422, Cleveland, OH 44106, USA. Electronic address: chk@cwru.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 TW008067</GrantID>
            <Acronym>TW</Acronym>
            <Agency>FIC NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01TW008067</GrantID>
            <Acronym>TW</Acronym>
            <Agency>FIC NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2013</Year>
          <Month>12</Month>
          <Day>12</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Acta Trop</MedlineTA>
        <NlmUniqueID>0370374</NlmUniqueID>
        <ISSNLinking>0001-706X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017281" MajorTopicYN="N">Cost of Illness</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004185" MajorTopicYN="Y">Disability Evaluation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006373" MajorTopicYN="N">Helminthiasis</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
          <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019057" MajorTopicYN="Y">Quality-Adjusted Life Years</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Burden of illness</Keyword>
        <Keyword MajorTopicYN="N">Cost of illness</Keyword>
        <Keyword MajorTopicYN="N">Disability</Keyword>
        <Keyword MajorTopicYN="N">Helminthiasis</Keyword>
        <Keyword MajorTopicYN="N">Quality of life</Keyword>
        <Keyword MajorTopicYN="N">Schistosomiasis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2013</Year>
          <Month>2</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2013</Year>
          <Month>11</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2013</Year>
          <Month>12</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2013</Year>
          <Month>12</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2013</Year>
          <Month>12</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2016</Year>
          <Month>1</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2016</Year>
          <Month>1</Month>
          <Day>1</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">24333545</ArticleId>
        <ArticleId IdType="mid">NIHMS549522</ArticleId>
        <ArticleId IdType="pmc">PMC4055550</ArticleId>
        <ArticleId IdType="doi">10.1016/j.actatropica.2013.12.001</ArticleId>
        <ArticleId IdType="pii">S0001-706X(13)00350-1</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Amazigo UO, Anago-Amanze CI, Okeibunor JC. Urinary schistosomiasis among school children in Nigeria: consequences of indigenous beliefs and water contact activities. J Biosoc Sci. 1997;29:9&#x2013;18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9881116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anand S, Hanson K. Disability-adjusted life years: a critical review. J Health Econ. 1997;16:685&#x2013;702.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10176779</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>.  Drugs for parasitic infections, Med Lett Drugs Ther. 2010:e1&#x2013;e20.  http://secure.medicalletter.org/para.</Citation>
        </Reference>
        <Reference>
          <Citation>Baird S, Hicks JH, Kremer M, Miguel E. Worms at Work: Long-run Impacts of Child Health Gains. Department of Economics, University of California; Berkeley, Berkeley, CA: 2011. p. 67.</Citation>
        </Reference>
        <Reference>
          <Citation>Banerjee AV, Duflo E. Poor Economics: A Radical Rethinking of the Way to Fight Global Poverty. Public Affairs; New York: 2011.</Citation>
        </Reference>
        <Reference>
          <Citation>Bustinduy AL, Parraga IM, Thomas CL, Mungai PL, Mutuku F, Muchiri EM, Kitron U, King CH. Impact of polyparasitic infections on anemia and undernutrition among Kenyan children Living in a Schistosoma haematobium-endemic area. Am J Trop Med Hyg. 2013;88:433&#x2013;440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3592521</ArticleId>
            <ArticleId IdType="pubmed">23324217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carabin H, Budke CM, Cowan LD, Willingham AL, 3rd, Torgerson PR. Methods for assessing the burden of parasitic zoonoses: echinococcosis and cysticercosis. Trends Parasitol. 2005;21:327&#x2013;333.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15922667</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carabin H, Ndimubanzi PC, Budke CM, Nguyen H, Qian Y, Cowan LD, Stoner JA, Rainwater E, Dickey M. Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis. 2011;5:e1152.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3101170</ArticleId>
            <ArticleId IdType="pubmed">21629722</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chan MS. The global burden of intestinal nematode infections--fifty years on. Parasitol Today. 1997;13:438&#x2013;443.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15275146</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Colley DG, Binder S, Campbell C, King CH, Tchuem Tchuente LA, N&#x2019;Goran EK, Erko B, Karanja DM, Kabatereine NB, van Lieshout L, Rathbun S. A five-country evaluation of a point-of-care Circulating Cathodic Antigen urine assay for the prevalence of Schistosoma mansoni. Am J Trop Med Hyg. 2013;88:426&#x2013;432.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3592520</ArticleId>
            <ArticleId IdType="pubmed">23339198</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Danso-Appiah A, De Vlas SJ, Bosompem KM, Habbema JD. Determinants of health-seeking behaviour for schistosomiasis-related symptoms in the context of integrating schistosomiasis control within the regular health services in Ghana. Trop Med Int Health. 2004;9:784&#x2013;794.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15228488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Engels D, Savioli L. Reconsidering the underestimated burden caused by neglected tropical diseases. Trends Parasitol. 2006;22:363&#x2013;366.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16798088</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ezeamama AE, Friedman JF, Acosta LP, Bellinger DC, Langdon GC, Manalo DL, Olveda RM, Kurtis JD, McGarvey ST. Helminth infection and cognitive impairment among Filipino children. Am J Trop Med Hyg. 2005a;72:540&#x2013;548.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1382476</ArticleId>
            <ArticleId IdType="pubmed">15891127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ezeamama AE, Friedman JF, Olveda RM, Acosta LP, Kurtis JD, Mor V, McGarvey ST. Functional significance of low-intensity polyparasite helminth infections in anemia. J Infect Dis. 2005b;192:2160&#x2013;2170.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16288383</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Furst T, Keiser J, Utzinger J. Global burden of human food-borne trematodiasis: a systematic review and meta-analysis. Lancet Infect Dis. 2012a;12:210&#x2013;221.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22108757</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Furst T, Silue KD, Ouattara M, N&#x2019;Goran DN, Adiossan LG, N&#x2019;Guessan Y, Zouzou F, Kone S, N&#x2019;Goran EK, Utzinger J. Schistosomiasis, soil-transmitted helminthiasis, and sociodemographic factors influence quality of life of adults in Cote d&#x2019;Ivoire. PLoS Negl Trop Dis. 2012b;6:e1855.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3464303</ArticleId>
            <ArticleId IdType="pubmed">23056662</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giboda M, Bergquist NR. Post-transmission schistosomiasis. Parasitol Today. 1999;15:307&#x2013;308.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10407373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. Oxford University Press; New York: 1996.</Citation>
        </Reference>
        <Reference>
          <Citation>Gold MR, Stevenson D, Fryback DG. HALYS and QALYS and DALYS, Oh My: similarities and differences in summary measures of population health. Annu Rev Public Health. 2002;23:115&#x2013;134.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11910057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guyatt H. Different approaches to modelling the cost-effectiveness of schistosomiasis control. Mem Inst Oswaldo Cruz. 1998;93(Suppl 1):75&#x2013;84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9921326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guyatt H. Do intestinal nematodes affect productivity in adulthood? Parasitol Today. 2000;16:153&#x2013;158.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10725902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gwatkin DR, Guillot M, Heuveline P. The burden of disease among the global poor. Lancet. 1999;354:586&#x2013;589.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10470717</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hansson LF, Norheim OF, Ruyter KW. Equality, explicitness, severity, and rigidity: the Oregon plan evaluated from a Scandinavian perspective. The Journal of medicine and philosophy. 1994;19:343&#x2013;366.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7996073</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jamison DT. Foreword to the Global Burden of Disease and Injury Series. In: Murray CJ, Lopez AD, editors. The Global Burden of Disease. Harvard School of Public Health/World Bank; Cambridge MA: 1996. pp. xv&#x2013;xxiii.</Citation>
        </Reference>
        <Reference>
          <Citation>Jamison DT. Investing in Health. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P, editors. Disease Control Priorities in Developing Countries. Oxford University Press and The World Bank; Washington DC: 2006. pp. 3&#x2013;34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21250309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P. Disease Control Priorities in Developing Countries 2/e. Oxford University Press; New York: 2006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21250323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jasrasaria R, Murray CJ, Naghavi M. GBD 2010 Estimnation Strategy Report for Schistosomiasis: Report to Expert Group. Institute for Health Metrics and Evaluation; Seattle, WA: 2012.</Citation>
        </Reference>
        <Reference>
          <Citation>Jia TW, Zhou XN, Wang XH, Utzinger J, Steinmann P, Wu XH. Assessment of the age-specific disability weight of chronic schistosomiasis japonica. Bull World Health Organ. 2007;85:458&#x2013;465.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2636356</ArticleId>
            <ArticleId IdType="pubmed">17639243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jia TW, Melville S, Utzinger J, King CH, Zhou XN. Soil-transmitted helminth reinfection after drug treatment: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2012;6:e1621.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3348161</ArticleId>
            <ArticleId IdType="pubmed">22590656</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jia TW, Utzinger J, Deng Y, Yang K, Li YY, Zhu JH, King CH, Zhou XN. Quantifying quality of life and disability of patients with advanced schistosomiasis japonica. PLoS Negl Trop Dis. 2011;5:e966.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3039691</ArticleId>
            <ArticleId IdType="pubmed">21358814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>King CH, Bertino AM. Asymmetries of poverty: why global burden of disease valuations underestimate the burden of neglected tropical diseases. PLoS Negl Trop Dis. 2008;2:e209.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2267491</ArticleId>
            <ArticleId IdType="pubmed">18365036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>King CH, Dickman K, Tisch DJ. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet. 2005;365:1561&#x2013;1569.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15866310</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>King CH, Keating CE, Muruka JF, Ouma JH, Houser H, Siongok TK, Mahmoud AA. Urinary tract morbidity in schistosomiasis haematobia: associations with age and intensity of infection in an endemic area of Coast Province, Kenya. Am J Trop Med Hyg. 1988;39:361&#x2013;368.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3142286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>King CH, Olbrych SK, Soon M, Singer ME, Carter J, Colley DG. Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review. PLoS Negl Trop Dis. 2011;5:e1321.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3176745</ArticleId>
            <ArticleId IdType="pubmed">21949893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kirigia JM. Economic evaluation in schistosomiasis: using the delphi technique to assess effectiveness. Acta Trop. 1997;64:175&#x2013;190.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9107365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kirigia JM. Economic evaluation in schistosomiasis: valuation of health states preferences. A research note. Health Econ. 1998;7:551&#x2013;556.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9809712</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Knopp S, Mgeni AF, Khamis IS, Steinmann P, Stothard JR, Rollinson D, Marti H, Utzinger J. Diagnosis of soil-transmitted helminths in the era of preventive chemotherapy: effect of multiple stool sampling and use of different diagnostic techniques. PLoS Negl Trop Dis. 2008;2:e331.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2570799</ArticleId>
            <ArticleId IdType="pubmed">18982057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Knopp S, Rinaldi L, Khamis IS, Stothard JR, Rollinson D, Maurelli MP, Steinmann P, Marti H, Cringoli G, Utzinger J. A single FLOTAC is more sensitive than triplicate Kato-Katz for the diagnosis of low-intensity soil-transmitted helminth infections. Trans R Soc Trop Med Hyg. 2009;103:347&#x2013;354.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19168197</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>LaBeaud AD. Why arboviruses can be neglected tropical diseases. PLoS Negl Trop Dis. 2008;2:e247.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2427179</ArticleId>
            <ArticleId IdType="pubmed">18575597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, De Leo D, Degenhardt L, Delossantos A, Denenberg J, Des Jarlais DC, Dharmaratne SD, Dorsey ER, Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V, Flaxman AD, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabriel SE, Gakidou E, Gaspari F, Gillum RF, Gonzalez-Medina D, Halasa YA, Haring D, Harrison JE, Havmoeller R, Hay RJ, Hoen B, Hotez PJ, Hoy D, Jacobsen KH, James SL, Jasrasaria R, Jayaraman S, Johns N, Karthikeyan G, Kassebaum N, Keren A, Khoo JP, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lipnick M, Lipshultz SE, Ohno SL, Mabweijano J, MacIntyre MF, Mallinger L, March L, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGrath J, Mensah GA, Merriman TR, Michaud C, Miller M, Miller TR, Mock C, Mocumbi AO, Mokdad AA, Moran A, Mulholland K, Nair MN, Naldi L, Narayan KM, Nasseri K, Norman P, O&#x2019;Donnell M, Omer SB, Ortblad K, Osborne R, Ozgediz D, Pahari B, Pandian JD, Rivero AP, Padilla RP, Perez-Ruiz F, Perico N, Phillips D, Pierce K, Pope CA, 3rd, Porrini E, Pourmalek F, Raju M, Ranganathan D, Rehm JT, Rein DB, Remuzzi G, Rivara FP, Roberts T, De Leon FR, Rosenfeld LC, Rushton L, Sacco RL, Salomon JA, Sampson U, Sanman E, Schwebel DC, Segui-Gomez M, Shepard DS, Singh D, Singleton J, Sliwa K, Smith E, Steer A, Taylor JA, Thomas B, Tleyjeh IM, Towbin JA, Truelsen T, Undurraga EA, Venketasubramanian N, Vijayakumar L, Vos T, Wagner GR, Wang M, Wang W, Watt K, Weinstock MA, Weintraub R, Wilkinson JD, Woolf AD, Wulf S, Yeh PH, Yip P, Zabetian A, Zheng ZJ, Lopez AD, Murray CJ, AlMazroa MA, Memish ZA. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Glo Burden bal of Disease Study 2010. Lancet. 2012;380:2095&#x2013;2128.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC10790329</ArticleId>
            <ArticleId IdType="pubmed">23245604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McGuire RA, Coelho PRP. Parasites, Pathogens, and Progress. MIT Press; Cambridge, MA: 2011.</Citation>
        </Reference>
        <Reference>
          <Citation>Mekheimar SI, Talaat M. School non-enrollment and its relation with health and schistosomiasis knowledge, attitudes and practices in rural Egypt. East Mediterr Health J. 2005;11:392&#x2013;401.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16602459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miguel E, Kremer M. Worms: Identifying impacts on education and health in the presence of treatment externalities. Econometrica. 2004;72:159&#x2013;217.</Citation>
        </Reference>
        <Reference>
          <Citation>Molyneux DH, Hotez PJ, Fenwick A. &#x201C;Rapid-impact interventions&#x201D;: how a policy of integrated control for Africa&#x2019;s neglected tropical diseases could benefit the poor. PLoS Med. 2005;2:e336.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1253619</ArticleId>
            <ArticleId IdType="pubmed">16212468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Molyneux DH, Hotez PJ, Fenwick A, Newman RD, Greenwood B, Sachs J. Neglected tropical diseases and the Global Fund. Lancet. 2009;373:296&#x2013;297.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19167564</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mott KE. Schistosomiasis. In: Murray CJL, Lopez A, Mathers CD, editors. The Global Epidemiology of Infectious Diseases. World Health Organization; Geneva: 2004.</Citation>
        </Reference>
        <Reference>
          <Citation>Murray CJ. Rethinking DALYs. In: Murray CJ, Lopez AD, editors. The Global Burden of Disease. Harvard School of Public Health/World Bank; Cambridge MA: 1996. pp. 1&#x2013;98.</Citation>
        </Reference>
        <Reference>
          <Citation>Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, Naghavi M, Salomon JA, Shibuya K, Vos T, Lopez AD. GBD 2010: a multi-investigator collaboration for global comparative descriptive epidemiology. Lancet. 2012a;380:2055&#x2013;2058.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23245598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, Naghavi M, Salomon JA, Shibuya K, Vos T, Wikler D, Lopez AD. GBD 2010: design, definitions, and metrics. Lancet. 2012b;380:2063&#x2013;2066.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23245602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basanez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabe E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, De Leo D, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, Edmond K, Elbaz A, Ali SE, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, Fevre EM, Finucane MM, Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FG, Fransen M, Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari F, Gillum RF, Gmel G, Gonzalez-Medina D, Gosselin R, Grainger R, Grant B, Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, Hall W, Haring D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan G, Kassebaum N, Kawakami N, Keren A, Khoo JP, King CH, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Laden F, Lalloo R, Laslett LL, Lathlean T, Leasher JL, Lee YY, Leigh J, Levinson D, Lim SS, Limb E, Lin JK, Lipnick M, Lipshultz SE, Liu W, Loane M, Ohno SL, Lyons R, Mabweijano J, MacIntyre MF, Malekzadeh R, Mallinger L, Manivannan S, Marcenes W, March L, Margolis DJ, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGill N, McGrath J, Medina-Mora ME, Meltzer M, Mensah GA, Merriman TR, Meyer AC, Miglioli V, Miller M, Miller TR, Mitchell PB, Mock C, Mocumbi AO, Moffitt TE, Mokdad AA, Monasta L, Montico M, Moradi-Lakeh M, Moran A, Morawska L, Mori R, Murdoch ME, Mwaniki MK, Naidoo K, Nair MN, Naldi L, Narayan KM, Nelson PK, Nelson RG, Nevitt MC, Newton CR, Nolte S, Norman P, Norman R, O&#x2019;Donnell M, O&#x2019;Hanlon S, Olives C, Omer SB, Ortblad K, Osborne R, Ozgediz D, Page A, Pahari B, Pandian JD, Rivero AP, Patten SB, Pearce N, Padilla RP, Perez-Ruiz F, Perico N, Pesudovs K, Phillips D, Phillips MR, Pierce K, Pion S, Polanczyk GV, Polinder S, Pope CA, 3rd, Popova S, Porrini E, Pourmalek F, Prince M, Pullan RL, Ramaiah KD, Ranganathan D, Razavi H, Regan M, Rehm JT, Rein DB, Remuzzi G, Richardson K, Rivara FP, Roberts T, Robinson C, De Leon FR, Ronfani L, Room R, Rosenfeld LC, Rushton L, Sacco RL, Saha S, Sampson U, Sanchez-Riera L, Sanman E, Schwebel DC, Scott JG, Segui-Gomez M, Shahraz S, Shepard DS, Shin H, Shivakoti R, Singh D, Singh GM, Singh JA, Singleton J, Sleet DA, Sliwa K, Smith E, Smith JL, Stapelberg NJ, Steer A, Steiner T, Stolk WA, Stovner LJ, Sudfeld C, Syed S, Tamburlini G, Tavakkoli M, Taylor HR, Taylor JA, Taylor WJ, Thomas B, Thomson WM, Thurston GD, Tleyjeh IM, Tonelli M, Towbin JA, Truelsen T, Tsilimbaris MK, Ubeda C, Undurraga EA, van der Werf MJ, van Os J, Vavilala MS, Venketasubramanian N, Wang M, Wang W, Watt K, Weatherall DJ, Weinstock MA, Weintraub R, Weisskopf MG, Weissman MM, White RA, Whiteford H, Wiebe N, Wiersma ST, Wilkinson JD, Williams HC, Williams SR, Witt E, Wolfe F, Woolf AD, Wulf S, Yeh PH, Zaidi AK, Zheng ZJ, Zonies D, Lopez AD. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990&#x2013;2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012c;380:2197&#x2013;2223.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23245608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murray CJL, Lopez AD. The Global Burden of Disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Harvard School of Public Health/World Bank; Cambridge MA: 1996.</Citation>
        </Reference>
        <Reference>
          <Citation>Ozier O. Exploiting Externalities to Estimate the Long-Term Effects of Early Childhood Deworming. Department of Economics, University of California at Berkeley; Berkeley, CA: 2011.</Citation>
        </Reference>
        <Reference>
          <Citation>Petitti DB. Meta-Analysis, Decision Analysis and Cost-Effectiveness Analysis. Oxford University Press; Oxford, UK: 2000.</Citation>
        </Reference>
        <Reference>
          <Citation>Quattrocchi G, Nicoletti A, Marin B, Bruno E, Druet-Cabanac M, Preux PM. Toxocariasis and epilepsy: systematic review and meta-analysis. PLoS Negl Trop Dis. 2012;6:e1775.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3419195</ArticleId>
            <ArticleId IdType="pubmed">22905274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Richter J. The impact of chemotherapy on morbidity due to schistosomiasis. Acta Trop. 2003;86:161&#x2013;183.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12745135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rollinson D, Knopp S, Levitz S, Stothard JR, Tchuente LA, Garba A, Mohammed KA, Schur N, Person B, Colley DG, Utzinger J. Time to set the agenda for schistosomiasis elimination. Acta Trop. 2012 (in press)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22580511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, Mokdad A, Begum N, Shah R, Karyana M, Kosen S, Farje MR, Moncada G, Dutta A, Sazawal S, Dyer A, Seiler J, Aboyans V, Baker L, Baxter A, Benjamin EJ, Bhalla K, Bin Abdulhak A, Blyth F, Bourne R, Braithwaite T, Brooks P, Brugha TS, Bryan-Hancock C, Buchbinder R, Burney P, Calabria B, Chen H, Chugh SS, Cooley R, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, Davis A, Degenhardt L, Diaz-Torne C, Dorsey ER, Driscoll T, Edmond K, Elbaz A, Ezzati M, Feigin V, Ferri CP, Flaxman AD, Flood L, Fransen M, Fuse K, Gabbe BJ, Gillum RF, Haagsma J, Harrison JE, Havmoeller R, Hay RJ, Hel-Baqui A, Hoek HW, Hoffman H, Hogeland E, Hoy D, Jarvis D, Karthikeyan G, Knowlton LM, Lathlean T, Leasher JL, Lim SS, Lipshultz SE, Lopez AD, Lozano R, Lyons R, Malekzadeh R, Marcenes W, March L, Margolis DJ, McGill N, McGrath J, Mensah GA, Meyer AC, Michaud C, Moran A, Mori R, Murdoch ME, Naldi L, Newton CR, Norman R, Omer SB, Osborne R, Pearce N, Perez-Ruiz F, Perico N, Pesudovs K, Phillips D, Pourmalek F, Prince M, Rehm JT, Remuzzi G, Richardson K, Room R, Saha S, Sampson U, Sanchez-Riera L, Segui-Gomez M, Shahraz S, Shibuya K, Singh D, Sliwa K, Smith E, Soerjomataram I, Steiner T, Stolk WA, Stovner LJ, Sudfeld C, Taylor HR, Tleyjeh IM, van der Werf MJ, Watson WL, Weatherall DJ, Weintraub R, Weisskopf MG, Whiteford H, Wilkinson JD, Woolf AD, Zheng ZJ, Murray CJ. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet. 2012;380:2129&#x2013;2143.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC10782811</ArticleId>
            <ArticleId IdType="pubmed">23245605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salomon JA, Vos T, Murray CJ. Disability weights for vision disorders in Global Burden of Disease study &#x2013; Authors&#x2019; reply. Lancet. 2013;381:23&#x2013;24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23266228</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Satayathum SA, Muchiri EM, Ouma JH, Whalen CC, King CH. Factors affecting infection or reinfection with Schistosoma haematobium in coastal Kenya: survival analysis during a nine-year, school-based treatment program. Am J Trop Med Hyg. 2006;75:83&#x2013;92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3419477</ArticleId>
            <ArticleId IdType="pubmed">16837713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taylor HR, Jonas JB, Keeffe J, Leasher J, Naidoo K, Pesudovs K, Resnikoff S. Disability weights for vision disorders in Global Burden of Disease study. Lancet. 2013;381:23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23266227</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Terer CC, Bustinduy AL, Magtanong RV, Muhoho N, Mungai PL, Muchiri EM, Kitron U, King CH, Mutuku FM. Evaluation of the health-related quality of life of children in Schistosoma haematobium-endemic communities in Kenya: a cross-sectional study. PLoS Neglected Tropical Diseases. 2013;7(3):e2106.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3591318</ArticleId>
            <ArticleId IdType="pubmed">23505590</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ukwandu NC, Nmorsi OP. The perception, beliefs and practices toward genitourinary schistosomiasis by inhabitants of selected endemic areas (Edo/Delta States) in south-eastern Nigeria. Rev Inst Med Trop Sao Paulo. 2004;46:209&#x2013;216.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15361973</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van der Werf MJ, de Vlas SJ. Report for WHO Parasitic Diseases and Vector Contol. Erasmus University; Rotterdam: 2001. Morbidity and infection with schistosomes or soil-transmitted helminths.</Citation>
        </Reference>
        <Reference>
          <Citation>Verani JR, Abudho B, Montgomery SP, Mwinzi PN, Shane HL, Butler SE, Karanja DM, Secor WE. Schistosomiasis among young children in Usoma, Kenya. Am J Trop Med Hyg. 2011;84:787&#x2013;791.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3083748</ArticleId>
            <ArticleId IdType="pubmed">21540390</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basanez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabe E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, De Leo D, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, Edmond K, Elbaz A, Ali SE, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, Fevre EM, Finucane MM, Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari F, Gillum RF, Gmel G, Gosselin R, Grainger R, Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, Hall W, Haring D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan G, Kassebaum N, Kawakami N, Keren A, Khoo JP, King CH, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lalloo R, Laslett LL, Lathlean T, Leasher JL, Lee YY, Leigh J, Lim SS, Limb E, Lin JK, Lipnick M, Lipshultz SE, Liu W, Loane M, Ohno SL, Lyons R, Ma J, Mabweijano J, MacIntyre MF, Malekzadeh R, Mallinger L, Manivannan S, Marcenes W, March L, Margolis DJ, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGill N, McGrath J, Medina-Mora ME, Meltzer M, Mensah GA, Merriman TR, Meyer AC, Miglioli V, Miller M, Miller TR, Mitchell PB, Mocumbi AO, Moffitt TE, Mokdad AA, Monasta L, Montico M, Moradi-Lakeh M, Moran A, Morawska L, Mori R, Murdoch ME, Mwaniki MK, Naidoo K, Nair MN, Naldi L, Narayan KM, Nelson PK, Nelson RG, Nevitt MC, Newton CR, Nolte S, Norman P, Norman R, O&#x2019;Donnell M, O&#x2019;Hanlon S, Olives C, Omer SB, Ortblad K, Osborne R, Ozgediz D, Page A, Pahari B, Pandian JD, Rivero AP, Patten SB, Pearce N, Padilla RP, Perez-Ruiz F, Perico N, Pesudovs K, Phillips D, Phillips MR, Pierce K, Pion S, Polanczyk GV, Polinder S, Pope CA, 3rd, Popova S, Porrini E, Pourmalek F, Prince M, Pullan RL, Ramaiah KD, Ranganathan D, Razavi H, Regan M, Rehm JT, Rein DB, Remuzzi G, Richardson K, Rivara FP, Roberts T, Robinson C, De Leon FR, Ronfani L, Room R, Rosenfeld LC, Rushton L, Sacco RL, Saha S, Sampson U, Sanchez-Riera L, Sanman E, Schwebel DC, Scott JG, Segui-Gomez M, Shahraz S, Shepard DS, Shin H, Shivakoti R, Singh D, Singh GM, Singh JA, Singleton J, Sleet DA, Sliwa K, Smith E, Smith JL, Stapelberg NJ, Steer A, Steiner T, Stolk WA, Stovner LJ, Sudfeld C, Syed S, Tamburlini G, Tavakkoli M, Taylor HR, Taylor JA, Taylor WJ, Thomas B, Thomson WM, Thurston GD, Tleyjeh IM, Tonelli M, Towbin JA, Truelsen T, Tsilimbaris MK, Ubeda C, Undurraga EA, van der Werf MJ, van Os J, Vavilala MS, Venketasubramanian N, Wang M, Wang W, Watt K, Weatherall DJ, Weinstock MA, Weintraub R, Weisskopf MG, Weissman MM, White RA, Whiteford H, Wiersma ST, Wilkinson JD, Williams HC, Williams SR, Witt E, Wolfe F, Woolf AD, Wulf S, Yeh PH, Zaidi AK, Zheng ZJ, Zonies D, Lopez AD, Murray CJ. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990&#x2013;2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2163&#x2013;2196.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6350784</ArticleId>
            <ArticleId IdType="pubmed">23245607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang X, Gurarie D, Mungai PL, Muchiri EM, Kitron U, King CH. Projecting the long-term impact of school- or community-based mass-treatment interventions for control of Schistosoma infection. PLoS Negl Trop Dis. 2012;6:e1903.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3499404</ArticleId>
            <ArticleId IdType="pubmed">23166850</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>WHO; Official Records of the World Health Organization, editor WHO definition of Health. Preamble to the Constitution of the World Health Organization; International Health Conference; N.Y. 19&#x2013;22 June, 1946; 1946.</Citation>
        </Reference>
        <Reference>
          <Citation>WHO. Preventive chemotherapy in human helminthiasis: coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers. World Health Organization; Geneva: 2006.</Citation>
        </Reference>
        <Reference>
          <Citation>WHO. Global programme to eliminate lymphatic filariasis: Annual report on lymphatic filariasis 2006. Weekly Epidemiol Rec. 2007;82:361&#x2013;380.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17948605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>WHO. Preventive Chemotherapy Databank. 2009.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">24326310</PMID>
      <DateCompleted>
        <Year>2016</Year>
        <Month>07</Month>
        <Day>21</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2015</Year>
        <Month>02</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1552-8456</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>37</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2015</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Western journal of nursing research</Title>
          <ISOAbbreviation>West J Nurs Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Structure determines medication errors in nursing units: a mechanistic approach.</ArticleTitle>
        <Pagination>
          <StartPage>299</StartPage>
          <EndPage>319</EndPage>
          <MedlinePgn>299-319</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/0193945913513849</ELocationID>
        <Abstract>
          <AbstractText>Medication errors have long been considered critical in global health care systems. However, few studies have been conducted to explore the effects of nursing unit structure on medication errors. The purpose of this study, therefore, was to determine the effects of structural factors on medication errors in nursing units. A total of 977 staff nurses and 62 head nurses participated in this cross-sectional design study. The findings show that professional autonomy (&#x3B2; = .53, t = 6.03, p &lt; .01), technology (&#x3B2; = .25, t = 3.02, p &lt; .01), and nursing experts (&#x3B2; = .52, t = 5.99, p &lt; .01) are predictors of medication error rates. This study shows that the structural factors influence medication administration and the mechanistic approach is specifically in relation of low medication error rates. The author suggests that head nurses should consider strategies that require adjustments to unit control mechanisms.</AbstractText>
          <CopyrightInformation>&#xA9; The Author(s) 2013.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hung</LastName>
            <ForeName>Chang-Chiao</ForeName>
            <Initials>CC</Initials>
            <AffiliationInfo>
              <Affiliation>Chang Gung University of Science and Technology, ChiaYi Campus, Taiwan, Republic of China cchung@gw.cgust.edu.tw.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Bih-O</ForeName>
            <Initials>BO</Initials>
            <AffiliationInfo>
              <Affiliation>Chang Gung University of Science and Technology, ChiaYi Campus, Taiwan, Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tsai</LastName>
            <ForeName>Shu-Ling</ForeName>
            <Initials>SL</Initials>
            <AffiliationInfo>
              <Affiliation>Chang Gung University of Science and Technology, ChiaYi Campus, Taiwan, Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tseng</LastName>
            <ForeName>Yun Shan</ForeName>
            <Initials>YS</Initials>
            <AffiliationInfo>
              <Affiliation>I-Shou University, Yanchao Campus, Taiwan, Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chang</LastName>
            <ForeName>Chia-Hao</ForeName>
            <Initials>CH</Initials>
            <AffiliationInfo>
              <Affiliation>Chang Gung University of Science and Technology, ChiaYi Campus, Taiwan, Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2013</Year>
          <Month>12</Month>
          <Day>10</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>West J Nurs Res</MedlineTA>
        <NlmUniqueID>7905435</NlmUniqueID>
        <ISSNLinking>0193-9459</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001291" MajorTopicYN="Y">Attitude of Health Personnel</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020811" MajorTopicYN="N">Biomedical Technology</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005104" MajorTopicYN="N">Expert Testimony</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008508" MajorTopicYN="N">Medication Errors</DescriptorName>
          <QualifierName UI="Q000451" MajorTopicYN="Y">nursing</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009741" MajorTopicYN="N">Nursing Staff, Hospital</DescriptorName>
          <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015279" MajorTopicYN="N">Organizational Culture</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017009" MajorTopicYN="N">Professional Autonomy</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">medication administration errors</Keyword>
        <Keyword MajorTopicYN="N">organizational structure</Keyword>
        <Keyword MajorTopicYN="N">participation in decision making</Keyword>
        <Keyword MajorTopicYN="N">professional autonomy</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2013</Year>
          <Month>12</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2013</Year>
          <Month>12</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2016</Year>
          <Month>7</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">24326310</ArticleId>
        <ArticleId IdType="doi">10.1177/0193945913513849</ArticleId>
        <ArticleId IdType="pii">0193945913513849</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">24046212</PMID>
      <DateCompleted>
        <Year>2015</Year>
        <Month>11</Month>
        <Day>27</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2017</Year>
        <Month>11</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-3318</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>24</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2015</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Tobacco control</Title>
          <ISOAbbreviation>Tob Control</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Pro-smoking apps: where, how and who are most at risk.</ArticleTitle>
        <Pagination>
          <StartPage>159</StartPage>
          <EndPage>161</EndPage>
          <MedlinePgn>159-61</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/tobaccocontrol-2013-051189</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Pro-smoking applications (app) provide information about brands of tobacco products, where to buy them, and encourage their use. It is unclear in which countries these apps are being downloaded, or whether app stores play a role in promoting or regulating these apps, particularly those that appear to target children.</AbstractText>
          <AbstractText Label="METHOD" NlmCategory="METHODS">The lifetime popularity of 107 pro-smoking apps was investigated, using a third-party app metrics service that aggregates data from app stores about app download popularity by country. Apps were deemed popular if at any time in their lifespan they achieved a top 25 ranking overall across all apps, or a top 25 ranking in any particular category of apps, such as 'educational games'.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifty-eight pro-smoking apps reached 'popularity' status in Apple and Android stores in one or more of 49 countries, particularly Italy, Egypt, Germany, Belgium and the USA. The daily downloads in each country ranged from approximately 2000 to 80&#x2005;000. The Apple store featured five of the pro-smoking apps in various categories, and two apps were featured by the Android market. Two pro-smoking apps in the Apple store were extremely popular in the 'Educational Games' and 'Kids' Games' categories.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Pro-smoking apps were popular in many countries. Most apps were assigned to entertainment and games categories, with some apps specifically targeting children through placement in categories directed at children. App stores that feature pro-smoking apps may be in violation of tobacco control laws.</AbstractText>
          <CopyrightInformation>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>BinDhim</LastName>
            <ForeName>Nasser F</ForeName>
            <Initials>NF</Initials>
            <AffiliationInfo>
              <Affiliation>School of Public Health, University of Sydney, Sydney, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Freeman</LastName>
            <ForeName>Becky</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>School of Public Health, University of Sydney, Sydney, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Trevena</LastName>
            <ForeName>Lyndal</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>School of Public Health, University of Sydney, Sydney, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2013</Year>
          <Month>09</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Tob Control</MedlineTA>
        <NlmUniqueID>9209612</NlmUniqueID>
        <ISSNLinking>0964-4563</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001530" MajorTopicYN="N">Belgium</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D040421" MajorTopicYN="N">Cell Phone</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004534" MajorTopicYN="N">Egypt</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005858" MajorTopicYN="N">Germany</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020407" MajorTopicYN="Y">Internet</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007558" MajorTopicYN="N">Italy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D040541" MajorTopicYN="N">Marketing</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D063731" MajorTopicYN="Y">Mobile Applications</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012907" MajorTopicYN="Y">Smoking</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062789" MajorTopicYN="Y">Tobacco Products</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014481" MajorTopicYN="N">United States</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Advertising and Promotion</Keyword>
        <Keyword MajorTopicYN="N">Global Health</Keyword>
        <Keyword MajorTopicYN="N">Prevention</Keyword>
        <Keyword MajorTopicYN="N">Tobacco Industry</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2013</Year>
          <Month>9</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2013</Year>
          <Month>9</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2015</Year>
          <Month>12</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">24046212</ArticleId>
        <ArticleId IdType="doi">10.1136/tobaccocontrol-2013-051189</ArticleId>
        <ArticleId IdType="pii">tobaccocontrol-2013-051189</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">24026163</PMID>
      <DateCompleted>
        <Year>2015</Year>
        <Month>07</Month>
        <Day>31</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-3318</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>24</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2015</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Tobacco control</Title>
          <ISOAbbreviation>Tob Control</ISOAbbreviation>
        </Journal>
        <ArticleTitle>What do we know about unassisted smoking cessation in Australia? A systematic review, 2005-2012.</ArticleTitle>
        <Pagination>
          <StartPage>18</StartPage>
          <EndPage>27</EndPage>
          <MedlinePgn>18-27</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/tobaccocontrol-2013-051019</ELocationID>
        <Abstract>
          <AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">A significant proportion of smokers who quit do so on their own without formal help (ie, without professionally or pharmacologically mediated assistance), yet research into how smokers quit focuses primarily on assisted methods of cessation.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of the present work was to systematically review recent smoking cessation research in Australia, a nation advanced in tobacco control, to determine what is known about smokers who quit unassisted in order to (1) inform a research agenda to develop greater understanding of the many smokers who quit unassisted and (2) elucidate possible lessons for policy and mass communication about cessation.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">In January 2013, four e-databases and the grey literature were searched for articles published between 2005 and 2012 on smoking cessation in Australia. Articles focusing solely on interventions designed to stimulate cessation were excluded, as were articles focusing solely on assisted cessation, leaving articles reporting on smokers who quit unassisted. Data from articles reporting on unassisted cessation were extracted and grouped into related categories.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 248 articles reported on smoking cessation, of which 63 focused solely on interventions designed to stimulate cessation, leaving 185 reporting on the method of cessation ('how' a smoker quits). Of these, 166 focused solely on assisted cessation, leaving 19 reporting, either directly or indirectly, on smokers who quit unassisted. Data from these studies indicated 54% to 69% of ex-smokers quit unassisted and 41% to 58% of current smokers had attempted to quit unassisted.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The majority of Australian smokers quit or attempt to quit unassisted, yet little research has been dedicated to understanding this process. Almost all research that reported unassisted cessation referenced it as a comparator to the focal point of assisted cessation. Public health may benefit from insights gained from greater research into the cessation method used by most smokers. Suggestions and a rationale for such research are provided.</AbstractText>
          <CopyrightInformation>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Smith</LastName>
            <ForeName>Andrea L</ForeName>
            <Initials>AL</Initials>
            <AffiliationInfo>
              <Affiliation>Sydney School of Public Health, The University of Sydney, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chapman</LastName>
            <ForeName>Simon</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Sydney School of Public Health, The University of Sydney, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dunlop</LastName>
            <ForeName>Sally M</ForeName>
            <Initials>SM</Initials>
            <AffiliationInfo>
              <Affiliation>Sydney School of Public Health, The University of Sydney, New South Wales, Australia Cancer Prevention Division, Cancer Institute NSW, Eveleigh, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
          <PublicationType UI="D000078182">Systematic Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2013</Year>
          <Month>09</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Tob Control</MedlineTA>
        <NlmUniqueID>9209612</NlmUniqueID>
        <ISSNLinking>0964-4563</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001315" MajorTopicYN="N">Australia</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016540" MajorTopicYN="N">Smoking Cessation</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000074606" MajorTopicYN="Y">Smoking Prevention</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Addiction</Keyword>
        <Keyword MajorTopicYN="N">Cessation</Keyword>
        <Keyword MajorTopicYN="N">Global health</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2013</Year>
          <Month>9</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2013</Year>
          <Month>9</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2015</Year>
          <Month>8</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">24026163</ArticleId>
        <ArticleId IdType="doi">10.1136/tobaccocontrol-2013-051019</ArticleId>
        <ArticleId IdType="pii">tobaccocontrol-2013-051019</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual">
      <PMID Version="1">23958643</PMID>
      <DateCompleted>
        <Year>2015</Year>
        <Month>10</Month>
        <Day>26</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2024</Year>
        <Month>11</Month>
        <Day>27</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1468-3318</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>24</Volume>
            <Issue>e1</Issue>
            <PubDate>
              <Year>2015</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Tobacco control</Title>
          <ISOAbbreviation>Tob Control</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Banning tobacco sales and advertisements near educational institutions may reduce students' tobacco use risk: evidence from Mumbai, India.</ArticleTitle>
        <Pagination>
          <StartPage>e100</StartPage>
          <EndPage>e107</EndPage>
          <MedlinePgn>e100-7</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/tobaccocontrol-2012-050819</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">India's Cigarettes and Other Tobacco Products Act bans tobacco sales and advertisements within 100 yards of educational institutions. In school-adjacent neighbourhoods in Mumbai, we assessed adherence to these policies and whether tobacco vendor and advertisement densities were associated with students' tobacco use.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">High school students' tobacco use was measured using a multistage cluster sampling survey (n=1533). Field geographic information systems data were obtained for all tobacco vendors and advertisements within 500 m of schools (n=26). Random-effects multilevel logistic regression was used to estimate associations of tobacco vendor and advertisement densities with ever tobacco use, current smokeless tobacco use and current tobacco use.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">There were 1741 tobacco vendors and 424 advertisements within 500 m of schools, with 221 vendors (13%) and 42 advertisements (10%) located within 100 m. School-adjacent tobacco vendor density within 100 m was not associated with the tobacco use outcomes, but tobacco advertisement density within 100 m was associated with all outcomes when comparing highest to lowest density tertiles: ever use (OR: 2.01; 95% CI 1.00 to 4.07), current use (2.23; 1.16, 4.28) and current smokeless tobacco use (2.01; 1.02, 3.98). Tobacco vendor density within 200, 300, 400 and 500 m of schools was associated with current tobacco use and current smokeless tobacco use, but not ever use.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The tobacco sales ban near educational institutions could be expanded beyond 100 m. Greater enforcement is needed regarding the current bans, particularly because advertisement density within 100 m of schools was associated with all students' tobacco use outcomes.</AbstractText>
          <CopyrightInformation>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mistry</LastName>
            <ForeName>Ritesh</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cancer Prevention and Control Research, University of California, Los Angeles, USA Department of Health Policy and Health Management, University of California, Los Angeles, USA Department of Health Behavior and Health Education, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pednekar</LastName>
            <ForeName>Mangesh</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Healis Sekhsaria Institute for Public Health, Navi Mumbai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pimple</LastName>
            <ForeName>Sharmila</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Preventive Oncology, Tata Memorial Hospital, Mumbai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gupta</LastName>
            <ForeName>Prakash C</ForeName>
            <Initials>PC</Initials>
            <AffiliationInfo>
              <Affiliation>Healis Sekhsaria Institute for Public Health, Navi Mumbai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McCarthy</LastName>
            <ForeName>William J</ForeName>
            <Initials>WJ</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cancer Prevention and Control Research, University of California, Los Angeles, USA Department of Health Policy and Health Management, University of California, Los Angeles, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Raute</LastName>
            <ForeName>Lalit J</ForeName>
            <Initials>LJ</Initials>
            <AffiliationInfo>
              <Affiliation>Healis Sekhsaria Institute for Public Health, Navi Mumbai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Patel</LastName>
            <ForeName>Minal</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cancer Prevention and Control Research, University of California, Los Angeles, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shastri</LastName>
            <ForeName>Surendra S</ForeName>
            <Initials>SS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Preventive Oncology, Tata Memorial Hospital, Mumbai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2013</Year>
          <Month>08</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Tob Control</MedlineTA>
        <NlmUniqueID>9209612</NlmUniqueID>
        <ISSNLinking>0964-4563</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003132" MajorTopicYN="N">Commerce</DescriptorName>
          <QualifierName UI="Q000331" MajorTopicYN="N">legislation &amp; jurisprudence</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D033161" MajorTopicYN="Y">Government Regulation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007194" MajorTopicYN="N">India</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D040541" MajorTopicYN="N">Marketing</DescriptorName>
          <QualifierName UI="Q000331" MajorTopicYN="Y">legislation &amp; jurisprudence</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011640" MajorTopicYN="N">Public Policy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012574" MajorTopicYN="Y">Schools</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000074606" MajorTopicYN="Y">Smoking Prevention</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013334" MajorTopicYN="N">Students</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019460" MajorTopicYN="N">Tobacco Industry</DescriptorName>
          <QualifierName UI="Q000331" MajorTopicYN="Y">legislation &amp; jurisprudence</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062789" MajorTopicYN="N">Tobacco Products</DescriptorName>
          <QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D064424" MajorTopicYN="Y">Tobacco Use</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014029" MajorTopicYN="N">Tobacco Use Disorder</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014030" MajorTopicYN="N">Tobacco, Smokeless</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Advertising and Promotion</Keyword>
        <Keyword MajorTopicYN="N">Global health</Keyword>
        <Keyword MajorTopicYN="N">Low/Middle income country</Keyword>
        <Keyword MajorTopicYN="N">Prevention</Keyword>
        <Keyword MajorTopicYN="N">Public policy</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2013</Year>
          <Month>8</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2013</Year>
          <Month>8</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2015</Year>
          <Month>10</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">23958643</ArticleId>
        <ArticleId IdType="doi">10.1136/tobaccocontrol-2012-050819</ArticleId>
        <ArticleId IdType="pii">tobaccocontrol-2012-050819</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">23343646</PMID>
      <DateCompleted>
        <Year>2016</Year>
        <Month>05</Month>
        <Day>04</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2018</Year>
        <Month>12</Month>
        <Day>02</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1941-2479</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>27</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2015</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Asia-Pacific journal of public health</Title>
          <ISOAbbreviation>Asia Pac J Public Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Mapping risk of Nipah virus transmission across Asia and across Bangladesh.</ArticleTitle>
        <Pagination>
          <StartPage>NP824</StartPage>
          <EndPage>NP832</EndPage>
          <MedlinePgn>NP824-32</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/1010539512471965</ELocationID>
        <Abstract>
          <AbstractText>Nipah virus is a highly pathogenic but poorly known paramyxovirus from South and Southeast Asia. In spite of the risks that it poses to human health, the geography and ecology of its occurrence remain little understood-the virus is basically known from Bangladesh and peninsular Malaysia, and little in between. In this contribution, I use documented occurrences of the virus to develop ecological niche-based maps summarizing its likely broader occurrence-although rangewide maps could not be developed that had significant predictive abilities, reflecting minimal sample sizes available, maps within Bangladesh were quite successful in identifying areas in which the virus is predictably present and likely transmitted.</AbstractText>
          <CopyrightInformation>&#xA9; 2013 APJPH.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Peterson</LastName>
            <ForeName>A Townsend</ForeName>
            <Initials>AT</Initials>
            <AffiliationInfo>
              <Affiliation>The University of Kansas, Lawrence, KS, USA town@ku.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2013</Year>
          <Month>01</Month>
          <Day>22</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>China</Country>
        <MedlineTA>Asia Pac J Public Health</MedlineTA>
        <NlmUniqueID>8708538</NlmUniqueID>
        <ISSNLinking>1010-5395</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001208" MajorTopicYN="N">Asia</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001459" MajorTopicYN="N">Bangladesh</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062305" MajorTopicYN="Y">Geographic Mapping</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D045464" MajorTopicYN="N">Henipavirus Infections</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000635" MajorTopicYN="Y">transmission</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D045405" MajorTopicYN="Y">Nipah Virus</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">communicable diseases</Keyword>
        <Keyword MajorTopicYN="N">epidemiology</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">population health</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2013</Year>
          <Month>1</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2013</Year>
          <Month>1</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2016</Year>
          <Month>5</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">23343646</ArticleId>
        <ArticleId IdType="doi">10.1177/1010539512471965</ArticleId>
        <ArticleId IdType="pii">1010539512471965</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">23000798</PMID>
      <DateCompleted>
        <Year>2016</Year>
        <Month>04</Month>
        <Day>27</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>12</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1941-2479</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>27</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2015</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Asia-Pacific journal of public health</Title>
          <ISOAbbreviation>Asia Pac J Public Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The environment modifies the relationship between social networks and secondhand smoke exposure among Korean nonsmokers in Seoul and California.</ArticleTitle>
        <Pagination>
          <StartPage>NP437</StartPage>
          <EndPage>NP447</EndPage>
          <MedlinePgn>NP437-47</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/1010539512459750</ELocationID>
        <Abstract>
          <AbstractText>This study compared risks of secondhand smoke exposure (SHSe) among Korean nonsmokers in Seoul, South Korea and California, United States. Social networks were hypothesized to contain more smokers in Seoul than in California, and smokers were hypothesized to produce more secondhand smoke in Seoul than California, as Seoul's policies and norms are less restrictive. Telephone interviews were conducted with Korean adults in Seoul (N = 500) and California (N = 2830). In all, 69% (95% confidence interval [CI] = 64-74) of Koreans and 31% (95% CI = 29-33) of Korean Americans reported any SHSe. A total of 44% (95% CI = 40-47) of Korean family members smoked versus 29% (95% CI = 28-30) of Korean American family members (t = 7.84, P &lt; .01). A 25% to 75% increase in the proportion of family members that smoked corresponded with a 13% (95% CI = 5-21) higher probability of any SHSe among Koreans compared with 6% (95% CI = 2-10) among Korean Americans. Network interventions in combination with policies and/or health campaigns may help reduce SHSe globally.</AbstractText>
          <CopyrightInformation>&#xA9; 2012 APJPH.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Allem</LastName>
            <ForeName>Jon-Patrick</ForeName>
            <Initials>JP</Initials>
            <AffiliationInfo>
              <Affiliation>University of Southern California Keck School of Medicine, Los Angeles, CA, USA allem@usc.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ayers</LastName>
            <ForeName>John W</ForeName>
            <Initials>JW</Initials>
            <AffiliationInfo>
              <Affiliation>Children's Hospital Informatics Program at the Harvard-MIT Division of Health Sciences and Technology, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Unger</LastName>
            <ForeName>Jennifer B</ForeName>
            <Initials>JB</Initials>
            <AffiliationInfo>
              <Affiliation>University of Southern California Keck School of Medicine, Los Angeles, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vollinger</LastName>
            <ForeName>Robert E</ForeName>
            <Initials>RE</Initials>
            <Suffix>Jr</Suffix>
            <AffiliationInfo>
              <Affiliation>Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Latkin</LastName>
            <ForeName>Carl</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Juon</LastName>
            <ForeName>Hee-Soon</ForeName>
            <Initials>HS</Initials>
            <AffiliationInfo>
              <Affiliation>Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Park</LastName>
            <ForeName>Hae-Ryun</ForeName>
            <Initials>HR</Initials>
            <AffiliationInfo>
              <Affiliation>Myongji University, Seoul, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Paik</LastName>
            <ForeName>Hee-Young</ForeName>
            <Initials>HY</Initials>
            <AffiliationInfo>
              <Affiliation>Seoul National University, Seoul, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hofstetter</LastName>
            <ForeName>C Richard</ForeName>
            <Initials>CR</Initials>
            <AffiliationInfo>
              <Affiliation>San Diego State University, San Diego, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hovell</LastName>
            <ForeName>Melbourne F</ForeName>
            <Initials>MF</Initials>
            <AffiliationInfo>
              <Affiliation>San Diego State University, San Diego, CA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 DA022961</GrantID>
            <Acronym>DA</Acronym>
            <Agency>NIDA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>RC1 AA018970</GrantID>
            <Acronym>AA</Acronym>
            <Agency>NIAAA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01CA105199</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D003160">Comparative Study</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2012</Year>
          <Month>09</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>China</Country>
        <MedlineTA>Asia Pac J Public Health</MedlineTA>
        <NlmUniqueID>8708538</NlmUniqueID>
        <ISSNLinking>1010-5395</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014028">Tobacco Smoke Pollution</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001213" MajorTopicYN="N">Asian</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002140" MajorTopicYN="N">California</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003431" MajorTopicYN="N">Cross-Cultural Comparison</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004777" MajorTopicYN="Y">Environment</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005190" MajorTopicYN="N">Family</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007398" MajorTopicYN="Y">Interpersonal Relations</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D056910" MajorTopicYN="N">Republic of Korea</DescriptorName>
          <QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D066106" MajorTopicYN="N">Seoul</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012944" MajorTopicYN="N">Social Support</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014028" MajorTopicYN="N">Tobacco Smoke Pollution</DescriptorName>
          <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">cross-cultural communication</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">population health</Keyword>
        <Keyword MajorTopicYN="N">smoke exposure</Keyword>
        <Keyword MajorTopicYN="N">smoking/tobacco/drug abuse</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2012</Year>
          <Month>9</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2012</Year>
          <Month>9</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2016</Year>
          <Month>4</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2015</Year>
          <Month>5</Month>
          <Day>26</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">23000798</ArticleId>
        <ArticleId IdType="mid">NIHMS690447</ArticleId>
        <ArticleId IdType="pmc">PMC4444048</ArticleId>
        <ArticleId IdType="doi">10.1177/1010539512459750</ArticleId>
        <ArticleId IdType="pii">1010539512459750</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Oberg M, Jaakkola MS, Woodward A, Peruga A, Pruss-Ustun A. Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet. 2011;377(9760):139&#x2013;146.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21112082</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>U.S. Department of Health and Human Services . The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. U.S. Department of Health and Human Services. Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; Atlanta, GA: 2006.</Citation>
        </Reference>
        <Reference>
          <Citation>California Environmental Protection Agency Air Resources Board. Initial Statement of Reasons for Rulemaking, Staff Report. Proposed Identification of Environmental Tobacco Smoke as a Toxic Air Contaminant. Dec;9:2005.</Citation>
        </Reference>
        <Reference>
          <Citation>IARC Handbooks of Cancer Prevention Tobacco Control. International Agency for Research on Cancer, World Health Organization, Volume 13. Evaluating the Effectiveness of Smoke-free Policies, Chapter 2, Health effects of exposure to secondhand smoke, (SHS) IARC. 2009</Citation>
        </Reference>
        <Reference>
          <Citation>Johnson KC, Miller AB, Collishaw NE, et al. Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk (2009). Tob Control. 2011;20(1):e2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21148114</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haw SJ, Gruer L. Changes in exposure of adult non-smokers to secondhand smoke after implementation of smoke-free legislation in Scotland: national cross sectional survey. BMJ. 2007;335(7619):549.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1976488</ArticleId>
            <ArticleId IdType="pubmed">17827485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thrasher JF, Perez-Hernandez R, Swayampakala K, Arillo-Santillan E, Bottai M. Policy support, norms, and secondhand smoke exposure before and after implementation of a comprehensive smoke-free law in Mexico city. Am J Public Health. 2010;100(9):1789&#x2013;1798.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2920995</ArticleId>
            <ArticleId IdType="pubmed">20466952</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cho HJ, Khang YH, Jun HJ, Kawachi I. Marital status and smoking in Korea: the influence of gender and age. Soc Sci Med. 2008;66(3):609&#x2013;619.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17996346</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jee SH, Samet JM, Ohrr H, Kim JH, Kim IS. Smoking and cancer risk in Korean men and women. Cancer Cause Control. 2004;15(4):341&#x2013;348.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15141135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chung W, Kim H, Lim S, Lee S, Cho K. Factors influencing cigarette smoking and quantified implications for anti-smoking policy: evidence from South Korea. Int J Public Health. 2009;54(6):409&#x2013;419.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19876596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khang YH, Yun SC, Cho HJ, Jung-Choi K. The impact of governmental antismoking policy on socioeconomic disparities in cigarette smoking in South Korea. Nicotine Tob Res. 2009;11(3):262&#x2013;269.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19251768</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Warner KE. The role of research in international tobacco control. Am J Public Health. 2005;95(6):976&#x2013;984.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1449294</ArticleId>
            <ArticleId IdType="pubmed">15914819</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Korean American Coalition &#x2013; Census Information Center  Population change by race and ethnicity, 1990-2000, USA, california, southern california, LA county, orange county, koreatown. California state university, korean american coalition-census information center. 2003  www.calstatela.edu/centers/ckaks/census/7203_tables.pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>Alamar B, Glantz SA. Effect of increased social unacceptability of cigarette smoking on reduction in cigarette consumption. Am J Public Health. 2006;96(8):1359&#x2013;1363.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1522108</ArticleId>
            <ArticleId IdType="pubmed">16809588</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention (CDC) State-specific prevalence and trends in adult cigarette smoking--United States, 1998-2007. MMWR. Morbidity and mortality weekly report. 2009;58(9):221&#x2013;226.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19282813</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hofstetter CR, Hovell MF, Lee J, et al. Tobacco use and acculturation among Californians of Korean descent: a behavioral epidemiological analysis. Nicotine Tob Res. 2004;6(3):481&#x2013;489.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15203782</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hovell MF, Wahlgren DR, Adams MA. The Logical and Empirical basis for the Behavioral Ecological. In: Ciclemente RJ, Crosby RA, Kegler M, editors. Emerging Theories in Health Promotion Practice and Research. Jossey-Bass; San Francisco, California: 2009. pp. 347&#x2013;385.</Citation>
        </Reference>
        <Reference>
          <Citation>Ayers JW, Hofstetter CR, Hughes SC, et al. Gender modifies the relationship between social networks and smoking among adults in Seoul, South Korea. Int J Public Health. 2010;55(6):609&#x2013;617.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2992131</ArticleId>
            <ArticleId IdType="pubmed">20217178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hofstetter CR, Hovell MF, Irvin VL, Ayers JW, Hughes SC, Kang S. It's others, not the police: smoking, reprimand, and fines among adults of Korean descent in California. Health Psychol. 2010;29(3):255&#x2013;261.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2877265</ArticleId>
            <ArticleId IdType="pubmed">20496979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hovell MF, Zakarian JM, Wahlgren DR, Matt GE, Emmons KM. Reported measures of environmental tobacco smoke exposure: trials and tribulations. Tob Control. 2000;9(Suppl 3):III22&#x2013;28.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1766315</ArticleId>
            <ArticleId IdType="pubmed">10982901</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>King G, Tomz M, Wittenberg J. Making the most of statistical analyses: improving interpretation and presentation. Am J Polit Sci. 2000;44(2):341&#x2013;355.</Citation>
        </Reference>
        <Reference>
          <Citation>Tong EK, Tang H, Tsoh J, Wong C, Chen MS., Jr. Smoke-free policies among Asian-American women: comparisons by education status. Am J Prev Med. 2009;37(2 Suppl):S144&#x2013;150.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3992924</ArticleId>
            <ArticleId IdType="pubmed">19591754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee BE, Ha EH. Exposure to environmental tobacco smoke among South Korean adults: a cross-sectional study of the 2005 Korea National Health and Nutrition Examination Survey. Environ Health. 2011;10:29.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3076229</ArticleId>
            <ArticleId IdType="pubmed">21457578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>An N, Cochran SD, Mays VM, McCarthy WJ. Influence of American acculturation on cigarette smoking behaviors among Asian American subpopulations in California. Nicotine Tob Res. 2008;10(4):579&#x2013;587.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3652889</ArticleId>
            <ArticleId IdType="pubmed">18418780</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fong GT, Cummings KM, Borland R, et al. The conceptual framework of the International Tobacco Control (ITC) Policy Evaluation Project. Tob Control. 2006;15(Suppl 3):iii3&#x2013;11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2593053</ArticleId>
            <ArticleId IdType="pubmed">16754944</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hughes SC, Corcos IA, Hofstetter CR, et al. Home smoking restrictions among Koreans in Seoul. Asia-Pac J Public He. 2009;21(1):63&#x2013;70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19124337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nichter M, Muramoto M. Project Quit Tobacco International: laying the groundwork for tobacco cessation in low- and middle-income countries. Asia-Pac J Public He. 2010;22(3 Suppl):181S&#x2013;188S.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20566552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yong HH, Foong K, Borland R, et al. Support for and reported compliance among smokers with smoke-free policies in air-conditioned hospitality venues in Malaysia and Thailand: findings from the International Tobacco Control Southeast Asia Survey. Asia-Pac J Public He. 2010;22(1):98&#x2013;109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4411242</ArticleId>
            <ArticleId IdType="pubmed">20032039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jee SH, Ohrr H, Kim IS. Effects of husbands' smoking on the incidence of lung cancer in Korean women. Int J Epidemiol. 1999;28(5):824&#x2013;828.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10597977</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hovell MF, Wahlgren DR, Liles S, et al. Providing coaching and cotinine results to preteens to reduce their secondhand smoke exposure: a randomized trial. Chest. 2011;140(3):681&#x2013;689.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3168853</ArticleId>
            <ArticleId IdType="pubmed">21474574</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">22984132</PMID>
      <DateCompleted>
        <Year>2016</Year>
        <Month>05</Month>
        <Day>09</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2018</Year>
        <Month>12</Month>
        <Day>02</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1941-2479</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>27</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2015</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Asia-Pacific journal of public health</Title>
          <ISOAbbreviation>Asia Pac J Public Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>What affects Clean Delivery Kit utilization at birth in Nepal? A qualitative study.</ArticleTitle>
        <Pagination>
          <StartPage>NP1263</StartPage>
          <EndPage>NP1272</EndPage>
          <MedlinePgn>NP1263-72</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/1010539512458950</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Infection is one of the biggest causes of maternal and neonatal death in low-income countries. Clean Delivery Kits (CDKs) promote clean delivery and neonatal care. Our qualitative research explores reasons for low CDK utilization, and describes community perceptions of CDKs in Nepal.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We conducted 18 focus group discussions and 40 interviews with CDK users and nonusers, service providers, birth attendants, and household decision makers in 6 districts. We also conducted interviews with central level personnel. CDK users were aware of its benefits, and utilization was largely compatible with birth practices. Utilization was prevented by lack of awareness about the benefits and lack of availability. Participants believed that CDKs were for home use.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Poor promotion of CDK is related to the disjuncture of promoting CDK use, while encouraging institutional deliveries. If CDKs are made available and marketed for use in households and health institutions, utilization may increase.</AbstractText>
          <CopyrightInformation>&#xA9; 2012 APJPH.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Morrison</LastName>
            <ForeName>Joanna</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>University College London, London, UK joanna.morrison@ucl.ac.uk.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jacoby</LastName>
            <ForeName>Caroline</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Johns Hopkins Centre for Communication Programs, Baltimore, MD, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ghimire</LastName>
            <ForeName>Sagar</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Central Regional Health Directorate-Hetauda, Ministry of Health and Population, Nepal.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Oyloe</LastName>
            <ForeName>Peter</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Academy for Education and Development, Washington DC, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2012</Year>
          <Month>09</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>China</Country>
        <MedlineTA>Asia Pac J Public Health</MedlineTA>
        <NlmUniqueID>8708538</NlmUniqueID>
        <ISSNLinking>1010-5395</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003657" MajorTopicYN="N">Decision Making</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D036861" MajorTopicYN="N">Delivery, Obstetric</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004864" MajorTopicYN="N">Equipment and Supplies</DescriptorName>
          <QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017144" MajorTopicYN="N">Focus Groups</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006268" MajorTopicYN="N">Health Facilities</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006700" MajorTopicYN="Y">Home Childbirth</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007226" MajorTopicYN="N">Infant Mortality</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007407" MajorTopicYN="N">Interviews as Topic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008880" MajorTopicYN="Y">Midwifery</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009390" MajorTopicYN="N">Nepal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D036301" MajorTopicYN="N">Qualitative Research</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">child survival</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">health communication</Keyword>
        <Keyword MajorTopicYN="N">health systems</Keyword>
        <Keyword MajorTopicYN="N">maternal and child health</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2012</Year>
          <Month>9</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2012</Year>
          <Month>9</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2016</Year>
          <Month>5</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">22984132</ArticleId>
        <ArticleId IdType="doi">10.1177/1010539512458950</ArticleId>
        <ArticleId IdType="pii">1010539512458950</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">22743859</PMID>
      <DateCompleted>
        <Year>2016</Year>
        <Month>05</Month>
        <Day>09</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1941-2479</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>27</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2015</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Asia-Pacific journal of public health</Title>
          <ISOAbbreviation>Asia Pac J Public Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Migrant beer promoters' experiences accessing reproductive health care in Cambodia, Laos, Thailand, and Vietnam: lessons for planners and providers.</ArticleTitle>
        <Pagination>
          <StartPage>NP1228</StartPage>
          <EndPage>NP1240</EndPage>
          <MedlinePgn>NP1228-40</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/1010539512449854</ELocationID>
        <Abstract>
          <AbstractText>Migrant beer promoters in Cambodia, Laos, Thailand, and Vietnam were surveyed to determine their experiences in accessing reproductive health care services in the cities of Phnom Penh, Vientiane, Bangkok, and Hanoi. A total of 7 health care institutions were chosen as popular with migrant beer promoters. Staff at these institutions provided information on the institution, and 390 beer promoters were surveyed about their experiences while accessing services. There were discrepancies between findings from the staff interviews and the experiences of the beer promoters. In general, the migrant women were satisfied with the cost, location, friendliness of the health care providers, and knowledge and skills of the providers. They were less positive about confidentiality and waiting times, though many still agreed that these were not an issue. Health care planners and providers should take note of the issues affecting access to reproductive health care services for migrant women when they design and implement services.</AbstractText>
          <CopyrightInformation>&#xA9; 2012 APJPH.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Webber</LastName>
            <ForeName>Gail C</ForeName>
            <Initials>GC</Initials>
            <AffiliationInfo>
              <Affiliation>University of Ottawa, Ottawa, Canada gwebb035@uottawa.ca.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Spitzer</LastName>
            <ForeName>Denise L</ForeName>
            <Initials>DL</Initials>
            <AffiliationInfo>
              <Affiliation>University of Ottawa, Ottawa, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Somrongthong</LastName>
            <ForeName>Ratana</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Chulalongkorn University, Bangkok, Thailand.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dat</LastName>
            <ForeName>Truong Cong</ForeName>
            <Initials>TC</Initials>
            <AffiliationInfo>
              <Affiliation>Thai-Binh University, Thaibinh, Vietnam.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kounnavongsa</LastName>
            <ForeName>Somphone</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>National University of Laos, Vientiane, PDR Laos.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>103616-1</GrantID>
            <Acronym>CAPMC</Acronym>
            <Agency> CIHR</Agency>
            <Country>Canada</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2012</Year>
          <Month>06</Month>
          <Day>28</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>China</Country>
        <MedlineTA>Asia Pac J Public Health</MedlineTA>
        <NlmUniqueID>8708538</NlmUniqueID>
        <ISSNLinking>1010-5395</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001107" MajorTopicYN="Y">Architectural Accessibility</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001210" MajorTopicYN="N">Asia, Southeastern</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001515" MajorTopicYN="Y">Beer</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003132" MajorTopicYN="N">Commerce</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006268" MajorTopicYN="N">Health Facilities</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007407" MajorTopicYN="N">Interviews as Topic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D034121" MajorTopicYN="Y">Reproductive Health Services</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014171" MajorTopicYN="Y">Transients and Migrants</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <OtherID Source="NLM">CAMS3853</OtherID>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">gender issue/ethnicity</Keyword>
        <Keyword MajorTopicYN="N">global health</Keyword>
        <Keyword MajorTopicYN="N">health care services</Keyword>
        <Keyword MajorTopicYN="N">health equity</Keyword>
        <Keyword MajorTopicYN="N">inequalities in health</Keyword>
        <Keyword MajorTopicYN="N">primary health care</Keyword>
        <Keyword MajorTopicYN="N">public health</Keyword>
        <Keyword MajorTopicYN="N">social determinants of health</Keyword>
        <Keyword MajorTopicYN="N">women&#x2019;s health</Keyword>
      </KeywordList>
      <CoiStatement><b>Declaration of Conflicting Interests</b>. The author declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2012</Year>
          <Month>6</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2012</Year>
          <Month>6</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2016</Year>
          <Month>5</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2014</Year>
          <Month>2</Month>
          <Day>18</Day>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">22743859</ArticleId>
        <ArticleId IdType="mid">CAMS3853</ArticleId>
        <ArticleId IdType="pmc">PMC3928051</ArticleId>
        <ArticleId IdType="doi">10.1177/1010539512449854</ArticleId>
        <ArticleId IdType="pii">1010539512449854</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation> [Accessed October 16, 2011.];International Organization for Migration.   http://www.iom.int/jahia/Jahia/lang/en/pid/1.</Citation>
        </Reference>
        <Reference>
          <Citation>Munyewende P, Rispela LC, Harrisa B, Chersicha M. Exploring perceptions of HIV risk and health service access among Zimbabwean migrant women in Johannesburg: a gap in health policy in South Africa? J Public Health Policy. 2011;32(S1):S152&#x2013;S161.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21730988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bandyopadhyay M, Thomas J. Women migrant workers&#x2019; vulnerability to HIV infection in Hong Kong. AIDS Care. 2002;14:509&#x2013;521.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12204153</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hegde SS, Hoban E, Nevill A. Unsafe abortion as a birth control method: maternal mortality risks among unmarried Cambodian migrant women on the Thai-Cambodia border [published online ahead of print May 5, 2011] Asia Pac J Public Health. doi: 10.1177/1010539511409024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1010539511409024</ArticleId>
            <ArticleId IdType="pubmed">21551135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guerin PB, Allotey P, Elmi FH, Baho S. Advocacy as a means to an end: assisting refugee women to take control of their reproductive health needs. Women Health. 2006;43:7&#x2013;25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17135086</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anderson J, Reimer Kirkham S. Constructing nation: the gendering and racializing of the Canadian health care system. In: Strong-Boag V, Grace S, Eisenberg A, Anderson J, editors. Painting the Maple: Essays on Race, Gender, and the Construction of Canada. Vancouver, BC, Canada: UBC Press; 1998. pp. 242&#x2013;261.</Citation>
        </Reference>
        <Reference>
          <Citation>Spitzer DL. Visible bodies: minority women, nurses, time, and the new economy of care. Med Anthropol Q. 2004;18:490&#x2013;508.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15612412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>International Labour Organization. The Mekong Challenge: Cambodia&#x2019;s &#x201C;Beer Promotion Girls&#x201D; their recruitment, working conditions and vulnerabilities. Bangkok, Thailand: International Labour Office; 2006.</Citation>
        </Reference>
        <Reference>
          <Citation>Webber GC, Spitzer DL. Sexual and reproductive health issues facing Southeast Asian beer promoters: a qualitative pilot study. BMC Public Health. 2010;10:389.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2906467</ArticleId>
            <ArticleId IdType="pubmed">20594342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Phrasisombath K, Thomsen S, Hagberg J, Sychareun V, Faxelid E. Knowledge about sexually transmitted infections (STIs) and attitudes toward female sex workers with STI symptoms among health care providers in Laos [published online ahead of print July 31, 2011] Asia Pac J Public Health. doi: 10.1177/1010539511416223.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1010539511416223</ArticleId>
            <ArticleId IdType="pubmed">21807620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Webber GC, Spitzer D, Somrongthong R, Dat TC, Kounuavongsa S. Facilitators and Barriers to Accessing Reproductive Health Care for Migrant Beer Promoters in Cambodia, Laos, Thailand and Vietnam: A Mixed Methods Study. [Accepted for publication, 2012];Globalization and Health.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3475045</ArticleId>
            <ArticleId IdType="pubmed">22747607</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
